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In budding yeast, the phosphatase Cdc14 is released from nucleolus to promote 
mitotic exit (ME).  Cdc14 release and ME is controlled by mitotic cyclin-Cdk 
oscillation, the FEAR network including a non-proteolytic function of separase (Esp1), 
and the Mitotic Exit Network (MEN) indirectly activated by spindle elongation 
through cohesin cleavage by the proteolytic function of Esp1. 
 
The MEN contributes strongly to ME efficiency.  Esp1 contributes to Cdc14 
release and ME kinetics mainly through cohesin cleavage: the Esp1 requirement can 
be largely bypassed if cells are provided Esp1-independent means of separating sister 
chromatids.  In the absence of Esp1 activity we observed only a minor ME delay 
consistent with a FEAR defect.  Esp1 overexpression drives ME in Cdc20-depleted 
cells arrested in metaphase.  We have found that this activity of overexpressed Esp1 
depended on spindle integrity and the MEN.  Quantitative measure of Cdc14 
localization indicates efficient Cdc14 release upon MEN activation; release driven by 
Esp1 in the absence of microtubules was inefficient and incapable of driving ME. 
 
Reducing mitotic cyclin-Cdk activity is critical for ME, but Cdc14 release and 
resequestration is not blocked by endogenous undegradable mitotic cyclin Clb2.  
Using quantitative time-lapse microscopy, we demonstrate an intrinsic oscillatory 
module controlling Cdc14 localization.  This autonomous Cdc14 release oscillator 
functions at constant cyclin-Cdk levels by titrated introduction of undegradable Clb2, 
and at cell-cycle-average Clb2 levels given a block of cell cycle progression by actin 
depolymerization.  Using genetic manipulations, we demonstrate that this oscillator 
can operate in free-running cell cycles even without undegradable Clb2.  The 
Cdc14-Cdh1-Cdc5 negative feedback is the primary mechanism driving this release 
oscillator.  Its mechanism and regulation of its frequency by Clb2-Cdk, suggest the 
hypothesis that intrinsically autonomous Cdc14 release cycles are locked at once per 
cell cycle through entrainment by the cyclin-Cdk oscillator.  This concept 
incorporates autonomous cell cycle oscillators previously reported into a coherent cell 
cycle control by cyclin-Cdk oscillation, therefore, may have broad implications for 
the structure and evolution of eukaryotic cell cycle. 
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Chapter 1: Introduction 
 
 
 Mitotic exit (ME) is a transitional stage connecting mitosis to the start of the next 
cell cycle.  In budding yeast Saccharomyces cerevisiae, ME refers to a collection of 
events happening within ~15 minutes from anaphase until rebudding, including 
spindle disintegration, cytokinesis, mitotic cyclin inactivation, and DNA replication 
origin licensing.  It is important that those events should only happen during ME, 
and in the right sequence for a normal cell cycle progression.  Molecular 
mechanisms regulating ME involve phosphorylation/dephosphorylation, protein 
proteolysis, protein localization change, protein complex formation, and gene 
transcription.  A key issue is to understand what commits the cell to exit from 
mitosis, and how various ME events are controlled efficiently and accurately. 
 
 Cyclins and cyclin dependent kinase (Cdk) are at the center of the eukaryotic cell 
cycle control system (Morgan, 2007).  Mitotic cyclin-Cdk activity rises and falls 
once per cell cycle in all eukaryotes.  In budding yeast S. cerevisiae, mitotic cyclins 
(Clb1,2,3,4) are required for mitotic entry (spindle assemble and anaphase), however 
overexpression of mitotic cyclins prevents ME, resulting in telophase arrest (Surana et 
al., 1993).  If mitotic entry requires high mitotic cyclin-Cdk activity, and ME 
requires low Cdk activity (King et al., 1994; Murray and Kirschner, 1989), then the 
oscillation of mitotic cyclin-Cdk activity would render ME dependent on previous 
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mitotic entry, resulting a ‘ratchet’-like control of mitosis.  Ratchet-like control of this 
nature is most prominently documented in the case of DNA replication, where high 
cyclin-Cdk simultaneously blocks DNA replication origin reloading, and promotes 
firing of previously loaded origins; this control yields once-per-cell-cycle replication 
(Kearsey and Cotterill, 2003).  These ideas have been generalized to spindle 
morphogenesis, function and disassembly, and to mitotic control overall, although the 
evidence for these other systems is less complete. 
 
 In S. cerevisiae, the oscillation of mitotic cyclin-Cdk activity is primarily a 
product of periodic transcription and proteolysis.  The anaphase promoting complex 
(APC), bound to its activator Cdc20 and Cdh1, mediates Clb proteolysis (Visintin et 
al., 1997; Yeong et al., 2000).  Full activation of APC-Cdc20 complex at the 
metaphase-to-anaphase transition requires phosphorylation of APC subunits by 
mitotic cyclin-Cdk (Cross, 2003).  Active APC-Cdc20 mediates proteolysis of 
securin Pds1, resulting in activation of separase Esp1 (Cohen-Fix et al., 1996).  Esp1 
can cleave cohesin subunit Scc1 to promote anaphase (Uhlmann et al., 2000).  In S. 
cerevisiae, APC-Cdc20 partially degrades mitotic cyclins (Clb1,2) (Yeong et al., 
2000).  Further down-regulation of mitotic cyclin-Cdk activity requires APC-Cdh1 
and the stoichiometric inhibitor Sic1 (Mendenhall and Hodge, 1998).  
Phosphorylation of Cdh1 by Cdk prevents its interaction with APC and nuclear 
accumulation (Shirayama et al., 1998).  Cdh1 is dephosphorylated by the 
phosphatase Cdc14 during ME, and results in complete degradation of mitotic cyclins 
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(Jaspersen et al., 1999).  Sic1 can inhibit Clb-Cdk activity independent of 
proteolysis .  Both transcription and stability of Sic1 is cell cycle regulated (Verma 
et al., 1997).  Sic1 transcription in mitosis is activated primarily by Swi5, which is 
activated by Cdc14 through dephosphorylation (Toyn et al., 1997; Visintin et al., 
1998).  Cdc14 also dephosphorylates Sic1 to prevent its proteolysis (Visintin et al., 
1998).  
 
Cdc14 is a major phosphatase and a key regulator during ME, and is highly 
conserved among eukaryotic species.  In budding yeast, Cdc14 is essential for cell 
viability.  The activity of Cdc14 is mainly regulated through changing its localization.  
Cdc14 is sequestered in the nucleolus by the RENT complex (including Net1) during 
G1, S and G2; this probably sequesters it from most targets, and additionally, Net1 
may inhibit Cdc14 enzymatic activity; therefore, Cdc14 is likely inactive through this 
time (Shou et al., 1999; Visintin et al., 1999).  Cdc14 is released from Net1 and the 
nucleolus into the cytoplasm only during ME (Net1 is constitutively nucleolar).  
Three major pathways release Cdc14 from nucleolus, including the FEAR network 
(cdc Fourteen Early Anaphase Release) which is activated by a non-proteolytic 
function of separase Esp1 at early mitosis to promote a transient release of Cdc14; the 
MEN (Mitotic Exit Network) which is activated through the Tem1-Cdc15-Dbf2 signal 
transduction cascade to promote Cdc14 release in later mitosis; in addition, the polo 
kinase Cdc5 is essential for Cdc14 release, and is required for full activation of FEAR 
and MEN pathways (Bardin et al., 2000; Stegmeier and Amon, 2004; Stegmeier et al., 
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2002; Visintin et al., 2003).  Cdc5 can also promote Cdc14 release by 
phosphorylating Cdc14 and the RENT complex to promote their disassociation 
(Visintin et al., 2003).   
 
The FEAR network is activated by the non-proteolytic function of Esp1 in early 
mitosis (Sullivan and Uhlmann, 2003).  Esp1 can interact with Cdc55 (PP2A 
co-factor) to cause Net1 phosphorylation by mitotic cyclin-Cdk to promote a transient 
release of Cdc14 (Queralt et al., 2006).  Besides Esp1, Slk19 and Spo12 are also 
essential components for the FEAR network (Stegmeier et al., 2002).   
 
The MEN network (also called spindle orientation checkpoint, SPOC) is activated 
in response to anaphase which pushes the daughter-orientated spindle pole body (SPB) 
into the bud (Bardin et al., 2000).  Then the MEN component Tem1 which localizes at 
SPB gets close to the bud cortex where Tem1’s guanine exchange factor Lte1 sits.  
This movement of SPB could lead to the activation of Tem1, and leads to a serial 
activation of Cdc15 and Dbf2/Mob1 complex.  Dbf2 can phosphorylate Net1 to 
promote its disassociation with Cdc14.  BUB2 is essential for SPOC regulation of the 
MEN; in bub2Δ cells, the MEN network is likely near-constitutively active (Fesquet 
et al., 1999; Pereira et al., 2000).   
 
Cdc14 released by the MEN network induces mitotic cyclin-Cdk inactivation, and 
directly promotes cytokinesis (Stegmeier and Amon, 2004).  Cdc14 released by the 
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FEAR network can facilitate rDNA segregation, spindle elongation, and nuclear 
positioning (D'Amours et al., 2004; Higuchi and Uhlmann, 2005; Ross and Cohen-Fix, 
2004; Sullivan et al., 2004; Wang et al., 2004).   It has also been proposed that the 
MEN component Cdc15 need to be dephosphorylated by FEAR-released Cdc14 for 
full activation of the MEN network (Jaspersen and Morgan, 2000; Stegmeier et al., 
2002).  Cdc14 initially released by the FEAR network may promote MEN activity to 
induce additional Cdc14 release, and therefore, forms a positive feedback loop to 
cause rapid release of Cdc14 from nucleolus (Sullivan and Uhlmann, 2003).  The 
non-proteolytic function of Esp1 has been suggested to be essential for ME (Sullivan 
and Uhlmann, 2003), although the FEAR network components Slk19 and Spo12 are 
dispensable for the cell cycle.  In slk19 Δ and spo12Δ cells, ME is delayed by 10~15 
minutes (Stegmeier et al., 2002).  Preventing Net1 phosphorylation by mitotic 
cyclin-Cdk, proposed to be a key FEAR pathway event, also only delays ME by 10-15 





Figure 1.1.  Major proteins and their interactions in mitotic exit control system.  
Arrow heads stand for activating interactions; blunt heads stand for inhibitory 
interactions.  Abbreviations: P, phosphorylation; DP, dephosphorylation; U, 
ubiquitination; X, protein cleavage; [GAL], requiring overexpression from GAL1 
promoter; B, binding; G.Ex, guanine exchange reaction.  Green symbols: proteins in 
the FEAR network; Red symbols: proteins in the MEN network; Blue symbols: 
proteins involved in regulating cyclin-Cdk activity.  Those classifications are not 
exclusive.  The ‘+’ symbol in green stands for logic AND.  The inset panel shows 
modules in mitotic exit and their general interactions. 
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 The networks controlling Cdc14 release and ME are highly interdigitated (Fig. 
1.1).  Therefore, although many possible interactions have been reported, it is 
difficult to envisage the dynamical behavior of the system, and a comprehensible 
model is often complicated by less important interactions due to the lack of its 
dynamical information.  For example, the FEAR and the MEN networks can be 
activated in many different ways; it is still unclear how those pathways are activated 
in a normal cell cycle, because the experimental conditions to establish those 
interactions are generally different.  Especially, it is unclear about the role of 
cyclin-Cdk activity in controlling those pathways.  Most proteins involved in the 
system are potentially Cdk substrates with both positive and negative interactions.  It 
is also unclear whether Cdc14 release alone is sufficient to induce ME, since separase 
Esp1 and several MEN components have been reported to be directly involved in 
controlling ME events (Jensen et al., 2001; Jimenez et al., 2005; Tinker-Kulberg and 
Morgan, 1999). 
 
 This thesis is divided into two parts.  The first part addresses the question of 
which signal ultimately leads to ME, and the relative importance of various pathways 
in this process.  The second part tries addresses the question of how Cdc14 release 
and resequestration is controlled by mitotic cyclin-Cdk activities. 
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Chapter 2: Materials and Methods 
 
Strains and plasmids   
All strains are in the W303 background.  Their genotypes are shown in Table 2.1.  
Strain constructions were carried out by standard tetrad analysis and transformation 
methods.  We used strains containing a CDC14 allele endogenously tagged with YFP, 
in order to follow Cdc14 trafficking.   This CDC14-YFP was previously shown to 
fully complement, and to be competent for FEAR- and MEN-induced nucleolar exit 
(Pereira et al., 2002).   GAL1-CLB2kd-GFP was constructed by C-terminally tagging 
GAL1-CLB2kd construct with GFP, and integrated at URA3 locus. NET1-mCherry 
was constructed by C-terminally tagging the endogenous NET1 with mCherry.  
CDC5pr-GFP-PEST was first constructed on a plasmid, and inserted at the 
endogenous CDC5 locus. 
 
The pYL8 plasmid (pRS303-GALS-esp1frag.. esp1frag, created by truncating a 
2.6kb region from the ESP1 ORF using SphI) was linearized with BlpI and integrated 
into the genome to make esp1::GALS-ESP1. ESP1::GALS-ESP1 was made alike, but 
using plasmid pYL10 which had a full length ESP1 ORF under the GALS promoter. 
Correct number of integration was confirmed by real time PCR. The construction of  
PDS1-mdb esp1::GALS-EPS (or ESP1::GALS-ESP1) strains was the following: A 
pds1::LEU2 strain was first transformed with pYL7 (pRS406-PDS1-mdb, linearized 
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with MluI), then the URA3 marker in the resulting strain was counter-selected on 
G+FOA plates to obtain Leu- Ura- clones. The structure of the pop-out strain was 
confirmed by PCR and Southern blot. 
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Table 2.1.  Strains and Genotypes.  All strains are W303 background.  Strains 
construction is using standard methods. 
Strain name Genotype  
2151-7B bar1 w303 
YL0931 cdc20::MET-CDC20-TRP1 ura3::GAL-SIC1-4A-URA3 
YL1721 cdc20::MET-CDC20-TRP1 ura3::GAL-SIC1-4A-URA3 
2147-3D cdc20::LEU2 ade2::GALL-CDC20-ADE2 pds1::URA3 
YL094 cdc20::MET-CDC20-TRP1 esp1-2td-URA3 GAL-UBR1-HIS3 ura3::GAL-SIC1-4A-URA3 leu2::ESP1C1531A-LEU2 
YL122 cdc20::MET-CDC20-TRP1 GFP-TUB1-HIS3  MYO1-GFP-KAN ESP1::GALS-ESP1C1531A-URA3 
YL353 cdc20::MET-CDC20-TRP1 scc1::HIS3 SCC1-TEV-LEU2 GAL-TEV-TRP1 GAL-SIC1-4A-URA3 
353 cdc20::MET-CDC20-TRP1 scc1::HIS3 SCC1-TEV-LEU2 GAL-TEV-TRP1  
BD96B-4C cdc20::MET-CDC20-TRP1 GFP-TUB1-HIS3  MYO1-GFP-KAN 
YL113 pds1::PDS1-mdb ESP1::GALS-ESP1-TRP1 trp1::LacO-LEU2,TRP1 his3::LacR-GFP-HIS3 MYO1-GFP-KAN 
YL115 pds1::PDS1-mdb esp1::GALS-ESP1-TRP1 trp1::LacO-LEU2,TRP1 his3::LacR-GFP-HIS3 MYO1-GFP-KAN 
YL018 pds1::PDS1-mdb ESP1::GALS-ESP1-TRP1 
YL114 bar1 pds1::PDS1-mdb esp1::GALS-ESP1-TRP1 
YL139 bar1 pds1::PDS1-mdb-18MYC ESP1::GALS-ESP1-TRP1 
YL049 bar1 mad2::KAN scc1::HIS3 SCC1-TEV::LEU2 GAL-TEV-TRP1  
YL057 bar1 mad2::KAN scc1::HIS3 SCC1-TEV::LEU2 GAL-TEV-TRP1 GAL-PDS1-mdb-URA3 
YL044 bar1 mad2::KAN scc1-73 leu2::GAL-PDS1-mdb-LEU2  
YL0451 bar1 mad2::KAN leu2::GAL-PDS1-mdb-LEU2 
YL1361 cdc20::MET-CDC20-TRP1 ESP1::GALS-ESP1-URA3 CDC14-YFP-HIS3 NET1-CFP-KAN MYO1-GFP-KAN 
YL1362 cdc20::MET-CDC20-TRP1 ESP1::GALS-ESP1-URA3 cdc15-2 CDC14-YFP-HIS3 NET1-CFP-KAN 
YL121 cdc20::MET-CDC20-TRP1 ESP1::GALS-ESP1-URA3 
YL1451 cdc20::MET-CDC20-TRP1 trp1::6xGAL-ESP1 CDC14-YFP-HIS3 NET1-CFP-KAN 
YL1452 cdc20::MET-CDC20-TRP1 CDC14-YFP-HIS3 NET1-CFP-KAN 
ALG611 bar1 clb2::CLB2,kd trp1::2xGAL-SIC1-TRP1 CDC14-YFP-HIS3 NET1-CFP-KAN MYO1-mCherry-HIS3 
YL165 cdc20::MET-CDC20-TRP1 cdh1::LEU2 ESP1::GALS-ESP1-URA3 CDC14-YFP-HIS3 NET-CFP-KAN 
YL1701 net1::HIS3 CDC14-YFP-HIS3 RRN3-LEU2 GALS-ESP1 
YL161 net1::HIS3 CDC14-YFP-HIS3 RRN3-LEU2 cdc15-2 CLB2-MYC-TRP1 
YL1702 net1::HIS3 NOP1-DsRed-HIS3 RRN3-LEU2 CDC14-YFP-HIS3 
YL174 net1::HIS3 CDC14-YFP-HIS3 RRN3-LEU2 ura3::DsRed-NLS-URA3 cdc15-2 CLB2-MYC-TRP1 
YL0932 cdc20::MET-CDC20-TRP1 trp1::6xGAL-ESP1 ura3::GAL-SIC1-4A 
393 cdc20::MET-CDC20-TRP1 trp1::6xGAL-ESP1 
YL008 esp1::GALS-ESP1-TRP1 
YL009 ESP1::GALS-ESP1-TRP1 
YL0452 bar1 bub2::HIS3 leu2::GAL-PDS1-mdb-LEU2 
OCF1517.2 GAL-PDS1-mdb-LEU2 
YL134 cdc20::MET-CDC20-TRP1 clb5::HIS3 ESP1::GALS-ESP1-URA3 
YL143 cdc20::MET-CDC20-TRP1 CDC14-TAB6  ESP1::GALS-ESP1-URA3 
YL1461 cdc20::MET-CDC20-TRP1 trp1::GALS-CDC14-FLAG-TRP1  
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YL1462 cdc20::MET-CDC20-TRP1 trp1::GALS-CDC14-FLAG-TRP1 ESP1::GALS-ESP1-URA3 
YL169 cdc20::MET-CDC20-TRP1 mad2::URA3 ESP1::GALS-ESP1-URA3 MYO1-GFP-KAN 
YL1541 bar1 net1::HIS3 cdc15-2 RRN3-LEU2 
YL1542 bar1 net1::HIS3 RRN3-LEU2 
YL1722 cdc20::MET-CDC20-TRP1 ESP1::GALS-ESP1-URA3 GAL-SIC1-4A-URA3 
YL042 cdc20::MET-CDC20-TRP1 GAL-PDS1-mdb-18MYC-URA3 
YL043 cdc20::MET-CDC20-TRP1 GAL-PDS1-18MYC-URA3 
2147-3D pds1::URA3 cdc20::LEU2 ade2::GALL-CDC20-ADE2 
YL135 MET-CDC2-TRP1 GAL-SIC1-4A-URA3 PDS1-18MYC-LEU2 
YL1761 
MET-CDC20-TRP1  ura3::GAL-CLB2kd-URA3  adh1::ADH1pr-GAL4-rMR-URA3 CDC14-YFP-HIS3  NET1-mCherry-HIS3  
MYO1-GFP-KanMX 
YL1841 
MET-CDC20-TRP1  ura3::GAL-CLB2kd-GFP-URA3,HIS3  adh1::ADH1pr-GAL4-rMR-URA3 CDC14-YFP-HIS3  
NET1-mCherry-HIS3  MYO1-GFP-KanMX 
YL1851 
MET-CDC20-TRP1  ura3::GAL-CLB2kd-URA3  adh1::ADH1pr-GAL4-rMR-URA3 CDC14-YFP-HIS3  NET1-mCherry-HIS3  
MYO1-GFP-KanMX  CLN2::CLN2pr-GFP-PEST-URA3 
YL1941 
MET-CDC20-TRP1  ura3::GAL-CLB2kd-GFP-URA3,HIS3  adh1::ADH1pr-GAL4-rMR-URA3 CDC14-YFP-HIS3  
NET1-mCherry-HIS3  MYO1-GFP-KanMX  swi5::KanMX 
YL1971 ura3::GAL-SIC1-4A-URA3  CDC14-YFP-HIS3  NET1-mCherry-HIS3  MYO1-GFP-KanMX 
YL2061 
MET-CDC20-TRP1  ura3::GAL-CLB2kd-URA3  adh1::ADH1pr-GAL4-rMR-URA3 CDC14-YFP-HIS3  NET1-mCherry-HIS3  
MYO1-GFP-KanMX  CDC5::CDC5pr-GFP-PEST-TRP1 
YL2091 
MET-CDC20-TRP1  ura3::GAL-CLB2kd-GFP-URA3,HIS3  adh1::ADH1pr-GAL4-rMR-URA3 CDC14-YFP-HIS3  
NET1-mCherry-HIS3  MYO1-GFP-KanMX  cdh1::LEU2 
YL2201 
MET-CDC20-TRP1  ura3::GAL-CLB2kd-GFP-URA3,HIS3  adh1::ADH1pr-GAL4-rMR-URA3 CDC14-YFP-HIS3  
NET1-mCherry-HIS3  MYO1-GFP-KanMX  cdc15-2 
YL2211 
MET-CDC20-TRP1  ura3::GAL-CLB2kd-URA3  adh1::ADH1pr-GAL4-rMR-URA3 CDC14-YFP-HIS3  NET1-mCherry-HIS3  
MYO1-GFP-KanMX  CLB2::CLB2-GFP-HIS3 
YL2221 MET-CDC20-TRP1  CDC14-YFP-HIS3  NET1-mCherry-HIS3  MYO1-GFP-KanMX  bub2::HIS3  cdh1::LEU2 
YL2222 CDC14-YFP-HIS3  NET1-mCherry-HIS3  MYO1-GFP-KanMX  bub2::HIS3 
YL2241 
MET-CDC20-TRP1  ura3::GAL-CLB2kd-URA3  adh1::ADH1pr-GAL4-rMR-URA3 CDC14-YFP-HIS3  NET1-mCherry-HIS3  
MYO1-GFP-KanMX  CLB2::CLB2pr-GFP-PEST-LEU2 
YL2191 CDC14-YFP-HIS3  NET1-mCherry-HIS3  MYO1-KanMX  cdc5::KanMX  ura3::3x(CDC5dB)::URA3 
YL2261 
MET-CDC20-TRP1  CLB2::GAL-CLB2kd-URA3  adh1::ADH1pr-GAL4-rMR-URA3 CDC14-YFP-HIS3  NET1-mCherry-HIS3  
MYO1-GFP-KanMX  cdc5::KanMX  ura3::3x(CDC5dB)::URA3 
YL2271 CDC14-YFP-HIS3  NET1-mCherry-HIS3  MYO1-KanMX  bub2::HIS3  cdc5::GAL-URL-3HA-CDC5-KaxMX 
YL2272 CDC14-YFP-HIS3  NET1-mCherry-HIS3  MYO1-KanMX  cdc5::GAL-URL-3HA-CDC5-KaxMX 
YL2291 CDC14-YFP-HIS3  NET1-mCherry-HIS3  MYO1-KanMX  bub2::HIS3  trp1::2x(GAL-SIC1)::TRP1 
YL1961 MATa clb1 clb2::GAL-CLB2  clb3::TRP1 clb4::his3::KanMX clb5::KanMX clb6::KanMX swe1::TRP1 
YL1962 MATa clb1 clb2::GAL-CLB2  clb3::TRP1 clb4::his3::KanMX clb5::KanMX clb6::KanMX swe1::TRP1 cdc14-1 
FC015 
MET-CDC20-TRP1  ura3::GAL-CLB2kd-GFP-URA3,HIS3  adh1::ADH1pr-GAL4-rMR-URA3 CDC14-YFP-HIS3  
NET1-mCherry-HIS3  MYO1-GFP-KanMX  cdc5-1 
YL2471 
MET-CDC20-TRP1  ura3::GAL-CLB2kd-GFP-URA3,HIS3  adh1::ADH1pr-GAL4-rMR-URA3 CDC14-YFP-HIS3  
NET1-mCherry-HIS3  MYO1-GFP-KanMX  spo12::KanMX 





CDC14-YFP-HIS3  NET1-mCherry-HIS3  MYO1-GFP-KanMX  bub2::HIS3  sic1::HIS3  cdh1::HIS3  
ade2::ADE2::GALL-CDC20 
YL2531 
MET-CDC20-TRP1  ura3::GAL-CLB2kd-GFP-URA3,HIS3  adh1::ADH1pr-GAL4-rMR-URA3 CDC14-YFP-HIS3  
NET1-mCherry-HIS3  MYO1-GFP-KanMX  cdc15-2  bub2::HIS3 
YL2581 
MET-CDC20-TRP1  ura3::GAL-CLB2kd-GFP-URA3,HIS3  adh1::ADH1pr-GAL4-rMR-URA3 CDC14-YFP-HIS3  
NET1-mCherry-HIS3  MYO1-GFP-KanMX  net1::HIS3  net1-6Cdk-TEV-myc9-TRP1 
YL2051 
MET-CDC20-TRP1  ura3::GAL-CLB2kd-URA3  adh1::ADH1pr-GAL4-rMR-URA3 CDC14-YFP-HIS3  NET1-mCherry-HIS3  
MYO1-GFP-KanMX (p)CDC5-GFP-LEU2 
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Time course experiments 
For alpha factor block, 100nM alpha factor was used. For hydroxyurea (HU) 
block, 0.16M HU was used.  In both cases, cells were washed 3 times by 
centrifugation and resuspension in fresh media for release.  Arresting the 
MET3-CDC20 cell in metaphase was done by addition of methionine to culture 
medium, as described (Uhlmann et al., 2000), and release was done by centrifugation 
and resuspension in fresh medium lacking methionine.  15μg/ml nocodazole and 
10μg/ml benomyl were added to cultures for spindle depolymerization (note: in 
Figures this is referred to as ‘NOC’; we found that adding benomyl as well was 
important for obtaining a stable block).  Protein extraction, immunoblotting and 
Clb2-associated H1 kinase assay were performed as previously described (Wasch and 
Cross, 2002).  DNA flow cytometry was performed as previously described (Epstein 
and Cross, 1992).  Budding was assessed by microscopic observation.  Nuclear 
content was assessed by examining samples with nuclei stained with propidium iodide 
by fluorescence microscopy.  Growth curve including cell density and mean cell 
volume was obtained using a Beckman Coulter Z2 Coulter Counter. The final carbon 
source concentration was, Glucose: 2%, Galactose: 3%, Raffinose: 3%.  The 
MET-CDC20 block experiment in Figure 3.1 was performed in YEP medium, 
otherwise in SC medium.  The hydroxyurea and alpha factor block and release 
experiments were performed in SC medium. The alpha factor block and release 
experiments was performed in YEP medium.  The time course experiment in Figure 
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3.3 was performed in YEP medium.  When making a time-lapse movie, only SC 
medium was used. 
Time-lapse and fluorescence microscopy  
For time-lapse microscopy, cells were prepared as described in (Bean et al., 2006).  
We used a Leica DMIRE2 inverted fluorescence microscope equipped with an 
environmental chamber and objective heater to observe the growth of the yeast cells 
at various temperatures.  Images were acquired every 3 minutes with a Hamamatsu 
Orca-ER camera.  We used custom Visual Basic software integrated with 
Image-Pro5.0 for microscope control and image acquisition.  For still-image 
fluorescent microscopy, cells were fixed with 4% paraformaldehyde for 10 minutes 
before microscopy.  For DAPI staining, cells were treated briefly with 30% ethanol 
following the paraformaldehyde fixation step, and stained with 100μg/ml DAPI. For 
imaging these cells, we used a Zeiss Axioplan2 fluorescent microscope with a 
Hamamatsu C4742-95 camera.  Openlab5.0 was used for microscope control and 
image acquisition.  Three Z-stacks at 0.6 micron intervals were taken for each 
fluorescent channel and projected onto a single image per channel.  
 
Pulse-expression of GAL1-CLB2kd(-GFP) in MET3-CDC20 blocked cells was 
described in Drapkin et al. (submitted). After Clb2kd expression, cells were 
immediately transferred to glucose medium without methionine at 30℃ to take 
fluorescent pictures every 3 minutes unless otherwise mentioned.  To measure the 
14
peak level of endogenous Clb2-GFP, MET3-CDC20 CLB2-GFP cells were grown up 
in glucose medium without methionine, and transferred into glucose medium with 
methionine to take time-lapse series.  Clb2-GFP level at MET3-CDC20 blocked cells 
was divided by 2 after background subtraction to be the peak Clb2-GFP in cycling 
cells; A population average was taken (the two-fold relationship between peak 
Clb2-GFP in cycling cells and that in MET3-CDC20 block was established in Drapkin 
et al. submitted). 
Image analysis 
Time-lapse movie segmentation and analysis was done using custom software as 
described in (Charvin et al., 2008). For the analysis of fluorescent microscopy 
pictures and r value calculation, we designed custom software in the Matlab 
environment. The Z-stack with the highest signal standard deviation was chosen for r 
value calculation.  r value was calculated by taking the average CDC14-YFP 
intensity of the brightest 5% pixels within a cell area, and subtracting the average of 
the dimmest 5% pixels; this value was then divided by a similar value for the 
NET1-CFP signal.  
 
In Chapter 4, we quantify Cdc14-YFP release by taking the coefficient of 
variation (CV, standard deviation divided by mean) of Cdc14-YFP pixel intensities 
inside a cell (mother and bud are treated separately), and divided by the CV of 
Net1-mCherry.  Bud emergence was detected visually; Cytokinesis was detected 
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using Myo1-GFP (in case Myo1 ring shrinking was slowed down by Clb2kd, we 
recorded the time when Myo1 ring shrinking was competed.); Nucleolar separation 
was defined as the initial stretching of Net1-mCherry signals, followed by a full 
separation in 3~6 minutes. A narrow band-width GFP filter (Chroma, 41020) allows 
for detection of GFP signals with little intervention from YFP spectrum.  
Subsequently, the GFP portion was subtracted from original YFP images to restore 
pure YFP images.  Control experiments with single-labeled cells (data not shown) 
indicate that this method yielded reliable quantifiable images without significant 
effective bleed-through between channels.  Bud-neck regions were always excluded 
from quantification since Cdc14-YFP can also localize during ME. SPB signaling of 
Cdc14-YFP was detected by identifying bright YFP pixels whose underlying mCherry 
signals were low.  Those pixels, if scored, were excluded from quantification, but did 
not cause any difference to our conclusions(Lu and Cross, 2009).  In net1Δ 
net1-6Cdk cells in Figure 4.14, Cdc14 release was quantified by taking 3 Z-stacks 
with 2 micron intervals.  And CV(Cdc14-YFP) in the best focused Z-stack was used 
to qualitatively reflect Cdc14 localization. 
Data analysis.  
All data analysis was performed using Matlab.  Fluorescence time-lapse series 
were extracted from movies as previously described(Charvin et al., 2008).  
Smoothing is performed using 3-neighbour averaging method. Because Clb2(kd)-GFP 
primarily localizes to the nucleus, we took the average GFP intensity of the brightest 
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10% pixels in a cell and divided it by the square root of the cell area to be the 
effective Clb2(kd)-GFP concentration (average over the first 5 frames).  Clb2kd 
concentration by this measure correlated best with graded ME delays.  Average GFP 
intensity in a cell was used to measure transcription using promoter-GFP-Pest 
fusions(Bean et al., 2006). 
Simulation of Kuramoto oscillator population with central 
pace-makers.  
Kuramoto oscillator networks containing 100 nodes were generated. The 







{0,1}, ∈jia  is the interaction matrix; λ  is the coupling strength. Network 
connections was either completely randomly established or using preferential 
attachments, and always kept the average in-degree <kin> and out-degree <kout> equal 
to 2.0 (i.e. on average, each node received 2 interactions and sent out 2 interactions). 
In preferential attachments(Barabasi and Albert, 1999), a network was grown from a 
small seed (N=2), and was gradually added nodes and links to it . For each node in the 
preexisted network, its chance of getting a new connection is in proportion to αk ( k 
is its degree;  α  is the preferential exponent). Preferential attachment was only 
applied to out-links. We scanned the coupling strength λ  from 0.1 to 3.0 with 100 
increments. For each λ , we randomly generated 1000 network connections with 
randomly chosen intrinsic frequencies ]1,1[−∈iω  and initial conditions 










||1 ϕ  (T=100, N=100) was used as the order parameter 
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to represent the degree of entrainment. All simulation was programmed in C language 
with Numerical Recipe 2.0 package. 
The conceptual model of phase-locking.   
The kinetics of the peripheral oscillator P and the Cdk oscillator C is governed by 
simple oscillator equations.  The free-running C can affect P’s frequency to establish 











=    (A: amplitude of C, )( PZ ϕ : P’s frequency response 














In Figure 4.19B, the frequency of Cdk oscillator 0.1=Cω  is a constant.  
Frequencies of the 3 peripheral oscillators Pω =[0.8  0.3  1.4], which roughly 
corresponds to budding, SPB duplication and Cdc14 release oscillator.  And Z0=[1.0  
7  1.7] respectively.  Cdk oscillation amplitude A=1.0.  Initial condition 
.0)0()0( ==== tt PC ϕϕ   In Figure 4.20A, let A=0.85, otherwise, identical to 
Figure 4.19B.  Simulation was done using Matlab. 










































































Parameter clb2 stands for Clb2kd concentration (/peak).  In Figure 4.13E, clb2=1.0;  
Initial condition=[0 0 0].  Simulation was done using Matlab.  
Calculation of Cdc14 release and SPB timing using 
phase-locking model 
Assume a peripheral oscillator P (such as bud emergence, SPB duplication, Cdc14 
release…) oscillates at frequency APf  at a specific locked Clb-Cdk level A (Any 
such level can be chosen provided it is permissive for oscillations of P).  Also 
assume the Clb-Cdk oscillator C oscillates at a constant frequency Cf  (i.e. the 
frequency of cell cycle).  Clb-Cdk activities above or below A could change the 
instantaneous frequency of P by the amount CSZf )(ϕ=Δ , where CS  is Clb-Cdk 
activity relative to the reference A ( AClbSC −= ), and )(ϕZ  is the phase response 
curve of P to Clb-Cdk activity, and is in general a function of P’s phaseϕ . 
 
According to experiments in Figure 4.10, only the inter-release period (from the 
end of last release to the beginning of the next) was reduced as Clb2kd level increased, 
but not the duration of Cdc14 release or release amplitude.  This observation will 
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restrict )(ϕZ  to the following form: 
)2,0[,   
)(     0
















In the unidirectional model, we ignore the feedback from P to C, and assume that 
Clb-Cdk activity oscillates as a function ))sin(1(*5.0 ψϕ ++ , where ψ  is the phase 
difference between P and C.  (The simple )sin( ψϕ +  function is altered by these 
arithmetic operations just to avoid biochemically nonsensical ‘negative’ Clb-Cdk 
activity, and to keep Clb-Cdk values between 0 and 1, where 1 corresponds to ‘1X 
peak’ in our experiments; see main text).  
 
To constitute an actual cell-cycle, P and C must oscillate with identical frequency 
averaging over each cell cycle and a stable phase difference. So we first look for the 
condition where the original frequency difference APC ff −  between C and P is 
compensated by Clb-Cdk oscillation. i. e. we look for a phase difference ψ  








1 dAZfff APC  
This formulation implies that at any instant, Clb-Cdk can either advance or retard the 
velocity of P through its cycle, depending on the coincidence of Z0 with Clb-Cdk 
above or below A.  







πϕψ π −><−+−= −
Z
ZAff APC  
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Note: In general, ψ  is also a function of ϕ . To obtain analytical results, we do the 
integration by approximating ψ  to a constant, meaning that the phase of P still 
progress smoothly. This approximation is exact when APC ff −  and )(ϕZ  are 
small (Winfree, 1967). Simulations with an ODE model show that with Z0, Cf  and 
A
Pf  in the range of our empirically determined values (see below), Z0 and 
A
PC ff −  
are small enough that this approximation is extremely close to the exact value (data 
not shown). 
 
Different phase-response curves )(ϕZ  will yield different stable solutions for 
ψ : therefore, oscillators entrained by different )(ϕZ  will cycle at different phases 
relative to the Clb-Cdk oscillator, potentially ordering cell cycle events. 
 
It’s demonstrable that the calculation of ψ  is independent of the choice of 
reference point A. APf is approximately a linearly function of constant Clb2kd levels 
A below 1.7xPeak (Figure 4.10B). Therefore, we write BAkf AP += * . k  is the 
slope of the linear fitting in Figure 4.10B, which is equal to average )(ϕZ  over one 







πϕψ π −><−−= −
Z
ZBfC ,  independent of A. 
For the convenience of calculation, the Clb-Cdk reference point is set at A=0.5. 
(MATLAB code for running this and related simulations are available upon request; 
we have found these simulations very helpful for aiding intuition). 
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The duration of Cdc14 release is approximately 20 minutes. From Figure 4.10, 
we estimate the period of the Cdc14 release oscillator at 1X peak Clb2kd at 70 
minutes, then we obtain πϕ
7
10
0 =  (For the Cdc14 oscillator, 0=ϕ  corresponds to 
the completion of Cdc14 resequestration).  For the estimation of πϕ 2)( >< Z (i.e. the 
slope of fitting in Figure 4.10B), we use only ‘category 3’ cells as defined in Figure 







><= ZZ , and obtain )min( 006.0022.0 1120
−− ⋅±= ClbPeakZ . 
 
When calculating Cdc14 entrainment phase, we took 5.0=A  as the reference 
point of stable Clb-Cdk, so that APf  is estimated at approximately the average 
Clb-Cdk activity in a cell cycle When Clb2kd<1X peak, the Cdc14 release oscillator 
is entrained or partially entrained into cell cycle due to endogenous Clb-Cdk 
oscillation, because at these low levels of Clb2kd, mitotic exit occurs and endogenous 
cyclin accumulates to sub-peak levels (data not shown).  For this reason, we lack 
endocycle data at Clb2kd=0.5, and we are obliged to linearly extrapolate the 
frequency response of Cdc14 release oscillator in Figure 4.10B to 0.5X peak Clb2kd. 




Pf .  For the frequency of Clb-Cdk cycles in wild-type 
mother cells, we take .)min( 801 =−Cf  based on abundant and reliable data for cycling 
wild-type cells (data not shown).  Since APf  and 0Z  measurements contain 
substantial uncertainty, we calculate ψ  at the average, +/- one standard deviation for 
each, summarized in the following table, and plotted below together with modeled 
Clb-Cdk levels (see Figure 4.20C legend): 
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    Z0 )min( 11 −− ⋅Peak   
fP-1 (min.) 
0.017 0.0224 0.028 
80 -0.71π -0.71π -0.71π 
95 -0.33π -0.47π -0.52π 
110 No solution No solution -0.30π 
 
(The lack of a solution in two cells of the table is likely due to oversimplifications in 
the model, such as describing )(ϕZ as a step function, which results in unrealistically 
tight boundary conditions). 
 
We next consider the phase-locking between SPB duplication oscillator and 
Clb-Cdk oscillator. This demonstration can be based only partially on empirical data, 
because in particular there is no quantitative information on the period of the SPB 
re-duplication cycle as a function of Clb levels.  According to previous studies, there 
is a licensing period following SPB separation when SPB reduplication is inhibited by 
high Clb-Cdk activity, but not in other parts of the SPB duplication cycle.  Therefore 
according to our formulation, 00 <Z   within the licensing period, 00 =Z  
elsewhere.  In cycling cells, the licensing period starts from SPB maturation in G2 
until the next G1.  For a typical cell cycle of 80 minutes (for mother cells), G1 lasts 
for ~20 minutes; S phase lasts for ~15 minutes. Therefore the licensing period is ~45 
minutes, and we have πϕ
8
9
0 =  ( 0=ϕ  corresponds to the beginning of the licensing 
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period, since by convention we set the beginning of the cycle to be the beginning of 
the part of the cycle affected by Clb2). 
 
While free oscillation of SPB duplication and cell-cycle-regulated transcription 
have been established, there is insufficient data to obtain empirical estimates of )(ϕZ  
and APf . The fact that SPB duplication is always entrained with cell cycle in wild 
type cells indicates that 0/)( Zff
A
PC −  should be small, which is easy to obtain 
with a large 0Z . Consistently, having Clb4 as the only mitotic cyclin completely 
blocks SPB reduplication (Haase et al., 2001), implying that the frequency of SPB 
oscillator is sensitive to Clb-Cdk levels, suggesting a large Z0. Therefore, we could 
assume 0/)( Zff
A









0 −=−=  solution is dynamically unstable due 
to 0Z <0) (Winfree, 1967). 
 
The stable solution restricts SPB duplication and maturation to the rising-phase of 
Clb-Cdk oscillator, roughly corresponding to G1  G2, which is physiologically 
meaningful. (See Figure 4.20 legend) 
Proof of linearity for the metric used to quantify Cdc14 
release 
At Cdc14 fully sequestered state: 
noise. is N and signal, YFP-Cdc14 real  theis S signal, observed  theis O      where:000 SNO +=
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When there is a fraction (1-λ) of Cdc14 released and become a uniform background C 
CSNCSNO ++=++= 01111 λ  
Assuming that Net1-mCherry is always nucleolar, and when Cdc14 is fully 









































The last step is obtained by assuming no covariance between Cdc14 signal and 
background noise.  
0),cov(),cov( 0010 == NSNS  
 
We can see that, even when Cdc14-YFP is completely released, λ=0, r is still >0 
due to background fluctuations. 
 
 
The bidirectional phase-locking model 
Cdc14 is not a simple peripheral oscillator, since it regulates Clb-Cdk activity 
(see main text).  Therefore, in a full account, it should be necessary to take mutual 
entrainment into account.  The fact that initial Cdc14 release and resequestration 
occur with normal kinetics at all levels of Clb2kd (main text) suggests, however, that 
the bidirectionality is not highly important in determining phasing of Cdc14 release 
relative to peak Clb2. 
 
To construct a bidirectional model, we adopt all basic assumptions in the 
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unidirectional model; in addition, assume there is also a feedback interaction from a 
peripheral oscillator P to the Cdk oscillator C. We named the coefficient of the 
interaction from C to P as )(ϕPCZ >− , and the one from P to C as )( ψϕ +>− CPZ , then 
the steady state condition reads 













Z PC  
 
In the case of Cdc14-release oscillator, we can get an analytical solution by 
assuming whenever there is Cdc14 release in a cell-cycle, there will be activation of 
Cdh1/Sic1 to inactivate Clb-Cdk, then we have =+>− )( ψϕCPZ constant. Therefore  
































ZAff PC  
0Z
ff PC Λ+−  needs to be determined experimentally. 
 
Due to the unknown parameterΛ , ψ  calculated using the bidirectional model 
can be different from the unidirectional model. But the same general conclusions hold 
for both models, such as 1. There will be at least one stable phase-locking solution ψ  
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giving strong enough coupling Z0; 2. Cell cycle oscillators with different 
phase-response curve )(ϕZ  could oscillate at different ψ , which may order the cell 
cycle.  
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Chapter 3: Mitotic Exit in The Absence of 
Separase Activity 
1. Background information 
Mitotic Exit (ME) is a complex set of events encompassing spindle disassembly, 
cyclin inactivation, cytokinesis and relicensing of replication origins.  In budding 
yeast Saccharomyces cerevisiae, the phosphatase Cdc14 is required for ME.  A first 
wave of Cdc14 release has been described in early anaphase, controlled by the 
separase-induced FEAR (cdc Fourteen Early Anaphase Release) network which 
includes separase (Esp1), Spo12, Slk19, Cdc5 (Stegmeier et al., 2002).  After DNA 
replication in S phase and kinetochore attachment, activated APC-Cdc20 commits the 
cell to chromosome segregation in anaphase by inducing the degradation of B-type 
cyclins and securin Pds1 to promote the onset of anaphase.   Pds1 forms a complex 
with Esp1, serving as its chaperone, and also inhibiting Esp1 proteolytic activity. 
After Pds1 proteolysis, free Esp1 may down-regulate phosphatase PP2A (Queralt et 
al., 2006), enhancing Net1 phosphorylation and promoting transient Cdc14 release 
(the FEAR network mechanism).  FEAR-released Cdc14 modulates nuclear 
movement, rDNA segregation and spindle stability before ME (Azzam et al., 2004).  
In later anaphase the release status of Cdc14 is maintained by a second mechanism, 
the Mitotic Exit Network (MEN), which involves Tem1, Cdc15, Dbf2/Mob1 and its 
inhibitor Bub2/Bfa1.  MEN activation may be due to Cdc14-dependent Cdc15 
dephosphorylation, spindle-elongation-induced Tem1 activation, or 
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Polo-kinase-induced Bub2/Bfa1 inactivation (Bardin et al., 2000; Hu et al., 2001; 
Jaspersen and Morgan, 2000).  
 
Current concepts place separase Esp1 at the center of ME regulation.  A 
non-proteolytic function of Esp1 is considered responsible for early anaphase release 
of Cdc14, perhaps to promote Cdc15 dephosphorylation to activate MEN.  MEN 
activity can promote additional Cdc14 release, thus forming a potential positive 
feedback loop, which could eventually release enough Cdc14 to drive ME.   
 
Although these concepts are supported by much experimentation, the ME system 
is highly complex, with interdigitated control networks making experimental design 
challenging, and straightforward interpretation sometimes difficult.  I attempted a 
factorial approach (Fisher, 1935) of independently controlling CDK inactivation, the 
non-proteolytic function of Esp1, and spindle elongation, aiming to achieve a 
balanced view of the relative contributions of three major regulators in ME.  These 
experiments have led me to a view of ME emphasizing the importance of CDK 
inactivation and activation of the MEN as the primary drivers.  In contrast to the 
proposal of a protease-independent essential role for Esp1 in ME, my results suggest 
that the primary contribution of Esp1 in ME is to promote sister chromatid separation, 
which leads to spindle-elongation-dependent MEN activation. 
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2. Factorial control of mitotic exit 
 
Complete factorial design of experiments employs systematic combinations of a 
set of controlling factors.  This approach allows determination not only of the 
contribution of each individual factor but also of interactions between them (Fisher, 
1935).  It is especially suitable and efficient for studying a complex system like the 
ME pathway for which I have little quantitative knowledge about the independence of 
its components.  
 
I chose three factors known to contribute to ME: Esp1 activation, cohesin 
cleavage and consequent spindle elongation, and CDK inactivation, as control points 
of the system (Figure 3.1A).  CDK inactivation, by degradation of mitotic cyclins 
such as Clb2, is essential for ME (Wasch and Cross, 2002). Another essential player 
that has been proposed is the non-proteolytic function of Esp1, which promotes 
spindle stability and FEAR network activity; however, the FEAR network has been 
found to be dispensable for ME in most studies (Jensen et al., 2001; Queralt et al., 
2006; Stegmeier et al., 2002).  My third factor, cohesin cleavage and consequent 
spindle elongation, activates MEN by promoting interaction of the daughter spindle 
pole body with the bud cortex (Bardin et al., 2000; Yeh et al., 1995).  Spindle 
elongation also creates the spindle mid-zone, a signaling center for Aurora kinase and 
the NoCut pathway (Norden et al., 2006).  
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A critical requirement for my approach is availability of tools to separately and 
independently manipulate those inputs.  Wherever possible, I have used multiple 
approaches to control each factor.  I prevent CDK inactivation in most experiments 
by blocking APC activation, using MET3-CDC20 strains incubated in methionine 
medium.  Conversely, I can promote CDK inactivation by over-expressing 
unphosphorylatable Sic1 from a galactose inducible promoter (GAL1-SIC1-4A) 
(Verma et al., 1997) or in some experiments by relying on the endogenous cyclin 
degradation system driven by the APC.  I control the presence of active Esp1 in most 
experiments by expressing undegradable Pds1 (Cohen-Fix et al., 1996), either from 
strong ectopic promoters or expressed from its endogenous locus.  I control spindle 
elongation independently of Esp1 by bypassing the Esp1 requirement for cohesin 
(Scc1) cleavage, using the TEV-Scc1-TEV-site system of Uhlmann et al. (Sullivan 
and Uhlmann, 2003; Uhlmann et al., 1999), or the scc1-73 temperature-sensitive 
allele (Michaelis et al., 1997).  Alternatively, in the presence of Esp1 I independently 
block spindle elongation using nocodazole, or MEN activation using the cdc15-2 
temperature-sensitive mutation.  Independence of these perturbations (that is, 
altering one input should not indirectly affect the others) is generally expected from 
the literature, and confirmed in my experiments wherever possible; however, 
complete independence of input modules can only be reached approximately. 
Therefore, I have strengthened my conclusions by alternative experimental designs 
for testing the same effective factor combinations wherever possible. 
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Figure 3.1.  Combinatorial control of mitotic exit by Cdk inactivation and cohesin 
cleavage, in the absence of Cdc20.  A. Major components and interactions in ME 
system; arrows: induction; bars: inhibition. Components indicated in red are exterior 
control points used here to manipulate the system. B. Cultures of MET3-CDC20 strains 
were first arrested in metaphase at 23°C by incubation in raffinose+methionine medium 
to deplete Cdc20, then galactose was added to the cultures to induce the expression of 
GAL1-TEV and GAL1-SIC1-4A where present. Methionine was kept in the medium 
throughout to maintain cdc20 depletion, except for the experiment labeled ‘control’, 
which was released into galactose medium lacking methionine to re-induce Cdc20. Strain 
genotypes: 1. “control”, MET3-CDC20 GAL1-SIC1-4A (YL1721). 2. “+ +”, 
MET3-CDC20 scc1Δ SCC1-TEV GAL1-TEV GAL1-SIC1-4A (YL353). 3. “+ –”, 
MET3-CDC20 scc1Δ SCC1-TEV GAL1-TEV (353). 4. “– +”, MET3-CDC20 
GAL1-SIC1-4A (YL1721). 5. “– –”, MET3-CDC20 (BD96b-4C). + +, + –, – + or – – 
indicate the presence or absence of GAL1-TEV/SCC1-TEV and GAL1-SIC1-4A. The 
fraction of large budded cells (excluding rebudded and small budded cells) was calculated 
from >200 cells at each time point.  DNA flow cytometry profiles from the beginning 
and end of the time course for each sample are shown (complete DNA flow cytometry 
data in Fig. 3.2), as well as sketches of the cell morphologies at the end of the experiment.  
Note that the elongated buds are a consequence of rebudding (with or without prior 
cytokinesis) in the presence of high Sic1 levels (Lew and Reed, 1993), and thus allow 
unambiguous discrimination between the large round buds found at the beginning of the 


















In the first series of experiments (Figure 3.1B), cells were arrested in metaphase 
using a methionine-suppressible MET3-CDC20 construct (Sullivan and Uhlmann, 
2003). Cdc20 is an essential activator of the APC, and in its absence cells arrest with 
high CDK activity due to mitotic cyclin stabilization (Yeong et al., 2000).  In 
addition, the Cdc20 target Pds1 accumulates at high levels, and anaphase is blocked 
due to Pds1 inhibition of Esp1 (Shirayama et al., 1999); therefore, I assume that Esp1 
activity is limited or absent.  I then examined if these cdc20-blocked cells can carry 
out mitotic exit, as a function of ectopic regulation of anaphase using the 
GAL1-TEV/SCC1-TEV system (Uhlmann et al., 2000), and of ectopic Clb-Cdk 
inactivation using GAL1-SIC1-4A (Verma et al., 1997).  To monitor ME, I employed 
phase contrast microscopy to detect cell division and budding, and DNA flow 
cytometry to analyze replication and effective chromosome segregation to daughter 
cells (implying cytokinesis and cell separation).  I were surprised to observe that 
simultaneously providing ectopic sources of cohesion cleavage and Clb-Cdk 
inactivation allowed quantitative and rapid mitotic exit, by the assays of cytokinesis, 
nuclear division and rebudding in the next cell cycle (Figure 3.1B), resulting in the 
efficient accumulation of 1C budded cells.  Of the two factors driving ME in this 
remarkably effective synthetically driven ME, CDK inactivation is essential, while 
TEV-mediated cohesin cleavage and consequent spindle elongation is important for 
efficiency but not absolutely required (Figure 3.1B).   
 
This experiment resembles one published by Sullivan and Uhlmann (2003), 
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except that in that work, clb5 deletion was employed for Clb-Cdk inhibition, which is 
very likely to provide only partial decrease in Clb-Cdk activity (as evidenced by 
viability of clb5 cells), while in contrast, GAL1-SIC1-4A quantitatively eliminates all 
Clb-Cdk activity and results in complete inviability (Figure 3.2B).  
 
Strikingly, timing of mitotic exit in the GAL1-SIC1-4A GAL1-TEV cdc20 cells 
was similar to that of cells released from the cdc20 block (Figure 3.1B, + + v.s. 
control). I assume that Esp1 was effectively inhibited by persistent Pds1 due to the 
cdc20 block, since anaphase was completely inhibited without GAL1-TEV expression. 
Therefore, these results suggest that ESP1 does not play a major role in ME besides 
its function in sister chromatid separation and the resulting spindle elongation.  
 
I further assessed the role of separase in ME in this protocol using a 
proteolytically inactive mutant ESP1C1531A (Uhlmann et al., 2000).  I constructed a 
MET3-CDC20 strain that contained the rapidly inactivatable esp1-2td allele (Queralt 
et al., 2006) as well as GAL1-SIC1-4A to allow Clb-Cdk inactivation and a copy of 
ESP1C1531A under control of the endogenous promoter.  As expected, release of the 
cdc20 block did not lead to anaphase in this strain. Employing the same set of assays 
for ME, I saw only the same partial mitotic exit phenotype that I could attribute to 
GAL1-SIC1-4A (Figure 3.1), with no detectable contribution from ESP1C1531A (Figure 







Figure 3.2.  A. DNA flow cytometry profile for time-courses in Figure 3.1. B. 
MET-CDC20 6xGAL-ESP1 (393) or MET-CDC20 6xGAL-ESP1 GAL-SIC1-4A 
(YL0932) was arrested in metaphase at 23° by incubation in raffinose+methionine 
medium to deplete Cdc20.  3% galactose was added to the culture at time zero. Clb2 
kinase assay, done as described in Materials and Methods, showed that GAL-SIC1-4A 
induction almost completely eliminated Clb2 kinase activity after 1 hour induction. C. 
MET-CDC20 esp1-2td GAL-UBR1 ESP1-C1531A GAL-SIC1-4A (YL094, separase +) 
was arrested at 25° by depleting Cdc20, followed by temperature shift to 37° to 
inactivate esp1-2td, and then Cdc20 was reintroduced by transferring to galactose 
medium lacking methionine. MET-CDC20 GAL-SIC1-4A (YL172, separase –) and 









3. Endogenous undegradable Pds1 blocks sister-chromatid 
separation 
 
I wanted to confirm that endogenous levels of Pds1 could effectively block Esp1 
activity in the absence of Cdc20-dependent Pds1 degradation, since this was an 
important assumption in the experiments described above.  Inviability of endogenous 
levels of Pds1-mdb was suggested by failure to recover transformants of PDS1-mdb 
under control of the PDS1 promoter in low-copy number plasmids (Cohen-Fix et al., 
1996), but the reason for the failure to recover these transformants was not elucidated.  
I constructed a PDS1-mdb allele at the endogenous locus, using exact gene 
replacement.  The potential lethality of this allele was overcome by mildly 
over-expressing Esp1 under a truncated GAL1 promoter (Mumberg et al., 1994), 
GALS-ESP1.  Indeed, this strain is fully viable on galactose media but inviable on 
glucose (Figure 3.3A), confirming that endogenous levels of undegraded Pds1 were 
lethal, specifically because of Esp1 sequestration.  Pds1-mdb was stable through the 
cell cycle at endogenous levels, while Pds1-wt was degraded before anaphase as 
expected (Figure 3.3B).  Since Esp1 is a stable protein, transcriptional repression of 
GALS-ESP1 by glucose in a PDS1-mdb background allows two or more near-normal 
cell cycles. Subsequently, I observe a gradual increase of unseparated chromosome 
dots (Bachant et al., 2005) (Figure 3.3C) and a gradual increase of large budded cells 
with 2C DNA content (Figure 3.4A).  These cells were highly delayed in ME, 
although ultimately most cells underwent aberrant mitosis with generation of 
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aneuploid or aploid cells (Figure 3.4A).  From these results, I conclude that the 
endogenous level of Pds1 can effectively inhibit Esp1 and block sister-chromatid 





Figure 3.3.  Endogenous undegradable Pds1 blocks sister-chromatid separation.  
A. PDS1-mdb ESP1::GALS-ESP1 (YL018) or a wild-type control were plated by 10x 
serial dilution on either glucose (D) or galactose (G) plates at 30° to assess viability. B. 
Cultures (PDS1-mdb-myc ESP1::GALS-ESP1 or control PDS1-wt-myc) synchronized 
by alpha-factor block-release were assayed by Western blotting with anti-Myc 
antibody. Pgk1 western blot was employed as a loading control. C. Endogenous Pds1 
is sufficient to block sister-chromatid separation. Glucose was added to 
galactose-grown mid-log cultures of PDS1-mdb trp1::LacO LacI-GFP, containing 
either esp1::GALS-ESP1 (YL115, filled bar) or ESP1::GALS-ESP1 (YL113, hatched 
bar).  Samples were fixed with paraformaldehyde and examined by fluorescence 
microscopy to score separation of the GFP-labeled chromosome ‘dots’. Fraction of 
large budded cells with unseparated GFP dots (red), with well-separated GFP dots 
(green) or closely separated GFP dots (blue) are shown. Cell morphologies at the 











Figure 3.4.  A. DNA flow cytometry profile: PDS1-mdb esp1::GALS-ESP1 (YL114) 
cells were grown to log phase in galactose media, then 2% glucose (Glu) was added at 
time zero. B. Growth curve: PDS1-mdb esp1::GALS-ESP1 (YL114) and PDS1-mdb 
ESP1::GALS-ESP1 (YL018) and esp1::GALS-ESP1 (YL008) strains growing in 
glucose or galactose. Cell density and mean cell volume were measured as described 
in Materials and Methods. 
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4. Inhibition of Esp1 by overexpression of overexpression of 
undegradable Pds1 blocks ME via blockage of cohesin 
cleavage 
 
Overexpression of undegradable Pds1 causes a complete block to anaphase, and a 
many-hour delay in ME (Cohen-Fix et al., 1996; Queralt et al., 2006; Sullivan and 
Uhlmann, 2003).  Consistently, in my experiments in Figure 3.1, Cdc20 depletion 
(leading to Pds1 accumulation and Esp1 inhibition), led to a significant delay in ME 
even when Clb-Cdk inhibition was provided ectopically by GAL1-SIC1-4A.   
However, this delay was efficiently rescued by ectopic cohesin cleavage using 
GAL1-TEV (Figure 3.1B), suggesting that most of the delay was due to failure of 
cohesin cleavage.  I were concerned, though, that I had not achieved complete Esp1 
inhibition using endogenous levels of accumulated Pds1.  To ensure that I achieved 
full inactivation of endogenous Esp1, I overexpressed Pds1-mdb from the GAL1 
promoter.  I expressed GAL1-PDS1-mdb expression for an hour to accumulate 
abundant Pds1-mdb in cdc20-blocked cells, and then released the cdc20 block by 
methionine removal.  In this protocol, Clb-Cdk inactivation is expected to proceed 
via the Cdc20-APC system, while Esp1 is sequestered by Pds1-mdb overexpression.  
I provided an ectopic source of cohesin cleavage using the GAL1-TEV/SCC1-TEV 
system.  As a control, I carried out the same protocol substituting GAL1-PDS1(wt), 
expressing the degradable form of Pds1, for GAL1-PDS1-mdb.  Expression of 
Pds1-mdb caused no delay in cytokinesis or Clb2 degradation compared to expression 
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of Pds1-wt, despite persistence of Pds1-mdb but not Pds1-wt, suggesting that Pds1 is 
not an effective ME inhibitor provided the need for the proteolytic activity of Esp1 is 
bypassed (Figure 3.5C).  While this experiment provides a direct comparison 
between Pds1-wt and Pds1-mdb at equally overexpressed levels, overexpressed 
Pds1-wt could delay ME compared to endogenous levels.  However, in the 





Figure 3.5.  Endogenous Esp1 is not necessary for efficient mitotic exit. A. 
Artificial cleavage of Scc1 with TEV protease ensures efficient ME in the absence of 
active Esp1. mad2Δ strains were arrested in S phase at 30°C with 0.16M hydroxyurea, 
and released into galactose with alpha factor. Pds1-mdb and TEV protease were 
overexpressed from the GAL1 promoter to inactivate Esp1 and to cleave Scc1-TEV 
(YL057). Strains lacking GAL1-TEV (YL045) GAL1-PDS1-mdb (YL049), or both 
(2151-7B) were used as controls. B. Inactivation of cohesin Scc1 restores the 
efficiency of ME in the absence of active Esp1. mad2 GAL1-PDS1-mdb strains, either 
scc1-73 (YL044) or SCC1 (YL045) were arrested by alpha factor at 25°C, then 
released into the absence of alpha factor either in galactose media to induce 
undegradable Pds1-mdb or raffinose as a control. Cultures were released at 37°C to 
inactivate cohesin (scc1-73). Alpha factor was reintroduced 1.5 hours post release to 
cause accumulation of cells in G1 after ME.  DNA flow cytometry was used to 
assess cell cycle progression. C. Pds1-mdb doesn’t independently block ME in cells 
provided with ectopic chromosome separation by TEV protease. 
GAL1-TEV/SCC1-TEV MET3-CDC20 strains, containing GAL1-PDS1-wt (YL042) or 
GAL1-PDS1-mdb (YL043), were arrested at the cdc20 block by incubation in 
raffinose plus methionine medium, and then pulsed with galactose plus methionine for 
an hour.  The cultures were then transferred into glucose without methionine to 
release the cdc20 block.  DNA content was measured by DNA flow cytometry, and 
Clb2 protein level by Western blot. Even loading was shown by amido-black staining 












I confirmed and extended this result using S-phase block with hydroxyurea, with 
the four combinations of presence or absence of GAL1-PDS1-mdb and 
GAL1-TEV/SCC1-TEV, all in the presence of wild-type endogenous PDS1.  Because 
premature cohesin cleavage can activate the Mad2-dependent spindle checkpoint 
(Severin et al., 2001), I carried out these experiments in a mad2Δ background.  In 
this protocol I allow the endogenous Cdc20-dependent Clb degradation system to 
eliminate Clb-Cdk activity and endogenous Pds1.  As previously reported 
(Cohen-Fix et al., 1996), Pds1-mdb overexpression blocks mitotic progression, but 
when chromosome separation is allowed by using GAL1-TEV/SCC1-TEV I observed 
efficient ME, which occurred almost as rapidly as in the GAL1-TEV/SCC1-TEV strain 
lacking GAL1-PDS1-mdb, or the wild-type control (Figure 3.5A).  The 
GAL1-PDS1-mdb GAL1-TEV/SCC1-TEV strain exhibited a delay of about 20 minutes 
judging from FACS and bud-count.  This delay was consistent with the ME delay in 
FEAR network mutants (Stegmeier et al., 2002), but much shorter than the >3-hour 
delay caused by GAL1-PDS1-mdb overexpression (Cohen-Fix et al., 1996) (Figure 
3.5A).  Therefore most of the long delay caused by Esp1 inhibition by Pds1-mdb 
overexpression is due to failure of cohesin cleavage.  
 
The temperature-sensitive scc1-73 cohesin allele (Michaelis et al., 1997) allows 
sister chromatid separation without Esp1 activity at restrictive temperature (Uhlmann 
et al., 1999).  I constructed mad2Δ strains that were scc1-73 or SCC1, with or 
without GAL1-PDS1-mdb, synchronized cells in G1 with alpha factor, and expressed 
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GAL1-PDS1-mdb for one hour before release at 37°C (restrictive temperature for 
scc1-73).  SCC1 GAL1-PDS1-mdb cells show a lengthy delay before ultimately 
undergoing aberrant ME with accumulation of aneuploid cells.  (Eventual 
accumulation of aneuploid cells is a consequence of GAL1-PDS1-mdb expression at 
37°C, where the G2 block is less stable than at 30°C.  This may be due to lower 
expression of GAL1-PDS1-mdb at 37°C) (Figure 3.5B).  In contrast, scc1-73 
GAL1-PDS1-mdb cells had indistinguishable ME kinetics compared to scc1-73 cells 
lacking GAL1-PDS1-mdb, and similar ME kinetics compared to SCC1 cells lacking 
GAL1-PDS1-mdb.   This result confirms that the GAL1-PDS1-mdb block to ME can 
be bypassed by cohesin inactivation.  Overall, three independent experiments (Figure 
3.5A-C) show that the Esp1 requirement for ME can be largely bypassed by 
complementing its proteolytic function in Scc1 inactivation.  This idea is also 
suggested by the similar kinetics of ME in cdc20-blocked cells with GAL1-SIC1-4A 
and GAL1-TEV overexpression to the kinetics of ME upon direct release of the cdc20 
block (Figure 3.1B).  
 
Stegmeier et al. (2002) carried out a similar experiment to the one in Figure 3.5B.  
Instead of inhibiting Esp1 with GAL1-PDS1-mdb, they used the esp1-1 
temperature-sensitive allele, and instead of scc1-73, they used the mcd1-1 
temperature-sensitive allele (MCD1 is the standard name for the cohesin subunit also 
named SCC1).  As in my experiment (Figure 3.5A), these strains (with the spindle 
checkpoint disabled by MAD1 deletion) were released from an alpha-factor block at 
48
non-permissive temperature.  They observed a significant reduction in ME delay by 
inclusion of mcd1-1 in the esp1-1 background, which is qualitatively similar to my 
findings. Distinct from my findings, they observed that the esp1-1 mcd1-1 strain 
exhibited a ~45 minutes delay in ME based on timing of mitotic cyclin (Clb2) 
degradation compared to the ESP1 mcd1-1 strain, whereas I observed little delay in 
ME based on direct examination of cytokinesis comparing the GAL1-PDS1-mdb 
strains that were SCC1-wt or scc1-73.  I do not know if the differences in results 
between my experiment and the results in Stegmeier et al. (2002) are due to 
differences between thermal inactivation of mcd1-1 vs. scc1-73, to the use of esp1-1 
vs. GAL1-PDS1-mdb to inhibit Esp1 activity, or to the difference in assay for ME.  
Many previous experiments support the efficacy of GAL1-PDS1-mdb in full inhibition 
of Esp1 (Cohen-Fix et al., 1996; Queralt et al., 2006; Sullivan and Uhlmann, 2003), 
and the results in Figure 3.5B are consistent with the results in Figure 3.5A using 
GAL1-TEV rather than scc1/mcd1 mutations to inactivate cohesin.  In a recently 
published similar experiment (Visintin et al., 2008), a mad1Δ GAL-PDS1Δdb mcd1-1 
strain exhibited a ME delay of 30 minutes or less.  This result is qualitatively 
consistent with my observations in Figure 3.5A-B. Variable delays in ME could be 
due to different experimental systems or limited resolution.  
 
Thus, I conclude that Esp1 is not required for ME in multiple experimental 
conditions, provided the requirement for cohesin cleavage is bypassed, although 
absence of Esp1 may cause a <30 min ME delay due to failure of FEAR network 
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activation.  I propose that provided sufficient Clb-Cdk inactivation, the timing of ME 
is largely regulated by the spindle-positioning-checkpoint regulating MEN activation, 
as proposed by Bardin et al. (2000).  Cohesin cleavage may be a requirement for 
efficient activation of the MEN by this mechanism, since anaphase spindle elongation 
requires cohesin cleavage, and anaphase efficiently drives one SPB into the bud. 
 
Consistent with the hypothesis that allowing cohesin cleavage bypasses the 
Pds1-mdb block by allowing spindle elongation and consequent MEN activation, the 
GAL1-PDS1-mdb block to cytokinesis can be effectively bypassed by ectopic 
activation of the MEN by deletion of the MEN inhibitor BUB2 in the absence of 
chromosome separation (Queralt et al., 2006); I have confirmed this result using HU 
block-release instead of cdc20 block-release (Figure 3.6).  I explore the connection 








Figure 3.6.  GAL-PDS1-mdb bub2∆ (YL0452) or BUB2 (OCF1517.2) strains were 
arrested in raffinose medium containing hydroxyurea as described in Materials and 
Methods, and released into galactose media lacking hydroxyurea at 30º. DNA flow 




5. Direct block of Scc1 cleavage delays ME in cells with 
active Esp1. 
The results above indicate that Esp1 contributes little to ME kinetics beyond its 
role in cohesin cleavage, leading to the conclusion that Esp1 is not necessary for quite 
efficient ME.  A converse question, so far not addressed in my experiments, 
concerns the ability of Esp1 to drive ME in cells in which cohesin cleavage and sister 
chromatid separation fails – is Esp1 sufficient to drive ME without cohesin cleavage?  
This question has been examined previously with the use of the non-cleavable version 
of Scc1 expressed from the GAL1 promoter (GAL1-SCC1-RRDD) (Uhlmann et al., 
1999).  In these experiments, blocking sister chromatid separation does not block 
Esp1 activation, since endogenous Scc1 is cleaved on schedule even in the presence 
of ectopic Scc1-RRDD (Uhlmann et al., 1999).  Blocking sister separation with 
Scc1-RRDD in the presence of active Esp1 causes a delay in ME estimated between 
20 to 60 minutes, depending on the assays for ME and/or on the exact experimental 
conditions (Stegmeier et al., 2002; Uhlmann et al., 2000).  I examined this question 
using a different assay, by time-lapse microscopy of GAL1-SCC1-RRDD cells 
pregrown in raffinose (uninduced) and plated on galactose medium to induce 
GAL1-SCC1-RRDD expression.  I observed a variable delay averaging ~1 hr 
between the first bud emergence (unaffected by SCC1-RRDD expression) and the 
second bud emergence, which requires prior ME, due to SCC1-RRDD expression 
(Table 3.1).  I included a Myo1-GFP marker (Bi et al., 1998) to allow measurement 
of the time between budding and cytokinesis (determined by Myo1 ring 
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disappearance), and observed a delay of ~0.5 hr due to SCC1-RRDD expression.  
The difference in delay times between these two assays is interesting and suggests 
that even in cells that complete cytokinesis, defects due to failure of cohesin cleavage 
cause an additional ~0.5 hr delay in rebudding.  Thus my results generally confirm 
the previous findings of a significant delay in ME solely due to failure of cohesin 
cleavage.  An advantage of my assay is that it requires no previous synchronization 
of the cells, which avoids potential artifacts, and in addition allows determination of 
the variability among individual cells, which can give misleading results in population 
studies.  Further, the method allows me to observe events preceding ME.  Using 
cells labeled with GFP-tubulin and blocked in metaphase by Scc1-RRDD, I observed 
rapid spindle oscillations, which pushed one SPB back and forth between daughter 
and mother cells (Palmer et al., 1989). This oscillatory movement could potentially 
activate the MEN by allowing one SPB to contact Lte1 near the bud cortex (Bardin et 
al., 2000).  This makes a complete assessment of Esp1’s contribution to ME in this 
experimental context difficult, since the spindle oscillations might activate the MEN 
without any Esp1 activity.  This difficulty was circumvented in the next section by 
using nocodazole to depolymerize the spindle. 
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Table 3.1.  Mitotic exit delay caused by noncleavable cohesin.  Strain 
GAL-SCC1-RRDD TUB1-GFP MYO1-GFP (YL066) was pre-grown in Raffinose 
medium, plated on galactose medium, and subjected to time-lapse analysis at 30°C or 
37°C as described in materials and methods. Cells that were unbudded at the time of 
plating were timed for both the interval from first budding to first cytokinesis 
(Myo1-GFP ring contraction and disappearance), and from first budding to the second 
budding. For comparison to other published data, we also carried this experiment out 
at 37°C; at this temperature, high fluorescent background prevented reliable 
assignment of time of cytokinesis, so only bud-to-bud times were assayed for initially 
unbudded cells.  Cells were classified according to whether the short spindle ended 
in the mother (Mo.) or the daughter cell (Da.). (At 30°C, almost 100% initially 
unbudded cells showed defective division, in which the spindle did not elongate but 
ended up intact in mother or daughter, in the first cell cycle. At 37°C, 35% initially 
unbudded cells elongated the spindle in spite of galactose addition, suggesting 
inefficient expression of GAL1-SCC1-RRDD at 37°C. Because we are tracking 
individual cells through time, we can exclude such cells from the analysis.) A 
MYO1-GFP TUB1-GFP strain lacking GAL1-SCC1-RRDD (BD78-2C) was treated in 
parallel as a control, pooling bud-to-bud data for mothers and daughters.  All 
numbers are in min +/- standard deviation.  The average differences (Δ) from 
wild-type are shown, and the P-value for these differences (by t-test). The numbers of 




















 WT 75±14  110±29  18
Mo. 102±20 (Δ 27 min) 5x10-3 169±60 (Δ 59 min) 1x10-2 11SCC1- 
RRDD Da. 112±21 (Δ 37 min) 1x10-4 228±59 (Δ 118 
min) 
1x10-5 19
37°C       
 WT ND  102±8  12
Mo. ND  153±28 (Δ 51 min) 1x10-4 9 SCC1- 






In any case, based on my and others’ results with GAL1-SCC1-RRDD, it is clear 
that blocking cohesin cleavage while allowing Esp1 activity causes a substantial delay 
in ME.  In turn, this suggests that the kinetics of ME in the wild-type cell cycle are 
driven by cohesin cleavage, since the time from cohesin cleavage to ME in wild-type 
cells is only ~15-20 minutes (Stegmeier et al., 2002), shorter than my estimate of the 
time required for ME in the presence of active Esp1, but without cohesin cleavage.  
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6. Mitotic exit promoted by Esp1 over-expression depends on 
spindle elongation and MEN activation  
 
Esp1 over-expression, but not TEV-induced spindle elongation, was shown to 
drive ME in cdc20-depleted cells, without a requirement for Esp1 proteolytic activity 
(Queralt et al., 2006; Sullivan and Uhlmann, 2003).  I have confirmed the finding 
that Esp1 overexpression drives ME in cdc20-depleted cells, even using the attenuated 
GALS promoter driving ESP1 instead of 6 copies of GAL1-ESP1 (Queralt et al., 2006; 
Sullivan and Uhlmann, 2003).  Expression of GALS-ESP1 still constitutes an 
approximately 30-fold overexpression based on comparison of accumulation of 
Myc-tagged Esp1 from the GALS vs. the endogenous promoter (data not shown).  It 
is also an effective overexpressor based on rescue of PDS1-mdb lethality; see above.  
For most purposes I prefer the GALS-ESP1 construct because it allows viability, 
unlike 6xGAL1-ESP1.  I found efficient induction of ME by GALS-ESP1, with all 
markers of ME (cytokinesis, rebudding, Clb2 degradation and DNA replication in the 
next cell cycle) occurring promptly upon GALS-ESP1 induction (Figure 3.7A).  This 
Esp1-induced ME was much more efficient than that described previously (Sullivan 
and Uhlmann, 2003).  This is likely a consequence of performing the experiment a. 
30° rather than at 23°. 6X GAL1-ESP1 also drove much more efficient ME at 30° than 
at 23° (Figure 3.8D). 
 
Thus, I confirm the previous finding (Sullivan and Uhlmann, 2003) that 
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overexpressed Esp1 drives ME in cdc20-blocked cells.  To further analyze this 
response, I tested if overexpressed Esp1 could drive ME in the presence of 
nocodazole to depolymerize the spindle.  Inclusion of nocodazole blocked ME in all 
aspects I have tested for at least 3 hours (Figure 3.7A).  Thus, overexpressed Esp1 
may not be intrinsically sufficient to drive ME in cdc20-depleted cells.  This ability 
of Esp1 may rely on spindle elongation consequent to cohesin cleavage by the 
proteolytic function of Esp1.  In these experiments I primarily used strains 
containing a CDC14 allele endogenously tagged with YFP, in order to follow Cdc14 
trafficking in later analysis (see below).  This CDC14-YFP was previously shown to 
fully complement, and to be competent for FEAR- and MEN-induced nucleolar exit 
(Pereira et al., 2002).  I also have confirmed key results in isogenic strains with 
untagged CDC14 (Figure 3.8A).  The involvement of the spindle integrity 
checkpoint surveillance system in this result seemed unlikely since the experiment 
was performed in a cdc20-depleted background, removing the target of the checkpoint 
(Hwang et al., 1998; Kim et al., 1998).  In addition, I have performed the same 
experiment in the absence of the essential spindle checkpoint component Mad2, with 
identical results (Figure 3.8B). 
 
Spindle elongation could promote ME by driving the daughter spindle pole into 
contact with the bud cortex, activating the MEN (Bardin et al., 2000; Stegmeier and 
Amon, 2004; Yeh et al., 1995).  To test this, I inhibited MEN activation with a 
temperature-sensitive cdc15-2 mutation (Cdc15 is an essential MEN component).  
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cdc15-2 completely inhibits GALS-ESP1-induced ME at 35.5°C (Figure 3.7B).  
 
Thus, promotion of ME by Esp1 overexpression in cdc20-blocked cells requires 
both an intact and a functional MEN, even if Clb-Cdk inhibition is provided 
ectopically.  I hypothesize that the requirement for spindle integrity for Esp1 
promotion of ME arises because Esp1-mediated cohesin cleavage allows spindle 
elongation, promoting effective contact between the daughter SPB and the bud cortex 







Figure 3.7.  Mitotic exit promoted by Esp1 overexpression depends on an intact 
spindle and MEN activation.  A. A MET3-CDC20 GALS-ESP1 strain (YL1361) 
was arrested by Cdc20 depletion, as in Fig. 3.1.  Esp1 was expressed from the GALS 
promoter at time zero by adding galactose (G) in the absence or presence of 
nocodazole + benomyl (NOC) (methionine was kept in the medium throughout to 
maintain Cdc20 depletion).  DNA flow cytometry and protein samples were taken. 
Microscopic examination allowed quantification of the following phenotypes: Black: 
large budded mononucleate cell. Red: large budded binucleate cell. Green: rebudded 
cell without cytokinesis. Blue: unbudded or small budded cell. (lower right).  
Squares: without nocodazole; circles: with nocodazole. Western blotting was used to 
assess the level of Clb2 (amido-black staining of the gels showed equal loading of all 
lanes [data not shown]). B. MET3-CDC20 GALS-ESP1 strains, either CDC15 
(YL1361) or cdc15-2 (YL1362) were treated and analyzed as in (A), except that the 
cultures were maintained at 35.5°C to inactivate cdc15-2.  Squares: CDC15-wt; 








Deletion of CLB5 may lower the threshold of Cdc14 activity required for 
triggering ME, since it rescues viability of cdc20 pds1 cells (Shirayama et al., 1999; 
Sullivan and Uhlmann, 2003).  Thus, CLB5 deletion might sensitize detection of an 
ability of Esp1 to drive ME, even without an intact spindle.  However, the result in 
Figure 3.7A is robust to deletion of CLB5, implying that spindle function is strongly 
required for GALS-ESP1-induced ME (Figure 3.8C).  
 
As shown in Figure 3.1, partial ME is obtainable with complete Clb-Cdk 
inhibition driven by GAL1-SIC1-4A, and ME becomes more efficient with concurrent 
expression of GAL1-TEV to provide cohesin cleavage.  I examined the ability of 
GALS-ESP1 to substitute for GAL1-TEV in this protocol, by a factorial experiment 
combining the presence or absence of GALS-ESP1 and of nocodazole, all in the 
presence of GAL-SIC1-4A. GALS-ESP1 promoted strong ME only in the absence of 
nocodazole.  In the presence of nocodazole, I observed the partial ME attributable to 
GAL1-SIC1-4A (Figure 3.1B), independent of the presence or absence of GALS-ESP1 
(Figure 3.9).  Thus, even with complete Clb-Cdk inhibition, I detect no 
ME-promoting activity of Esp1 in the presence of nocodazole. 
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Figure 3.8.  A. MET-CDC20 GALS-ESP1 (YL121) strain was arrested in Raffinose 
plus methionine, then experiments were performed as described in Fig. 3.7A. Results 
of DNA flow cytometry analysis and Clb2 western blot are shown. Even loading of 
samples were shown by amido-black staining (data not shown). B. A MET-CDC20 
mad2∆ GALS-ESP1 (YL169) strain was arrested by incubation in 
raffinose+methionine medium to deplete Cdc20. Galactose or 
Galactose+nocodazole+benomyl was added at time zero, keeping methionine present 
to maintain the cdc20 block. DNA flow cytometry and Clb2 western blot were 
performed as described in Materials and Methods. Pgk1 was employed as a loading 
control.  C. Nocodazole inhibited ME caused by Esp1 overexpression in the absence 
of Clb5. MET-CDC20 clb5∆ GALS-ESP1 (YL134) was arrested by incubation in 
raffinose+methionine medium to deplete Cdc20. Galactose or Galactose + nocodazole 
+ benomyl was added at time zero, keeping methionine present to maintain the cdc20- 
block. DNA flow cytometry and Western blot analysis were done as described in 
Materials and Methods. Samples were evenly loaded as shown by Amido-Black 
staining of the membrane after protein transfer (data not shown). The lower right 
panel shows the fraction of large budded cells. D. Esp1 overexpression induced more 
efficient ME at 30˚. MET-CDC20 6xGAL-ESP1 (strain 393, from F. Uhlmann) was 
arrested by incubation in raffinose+methionine medium to deplete Cdc20.  Galactose 
was added at time zero, keeping methionine present to maintain the cdc20- block, at 














Figure 3.9.  MET-CDC20 GAL-SIC1-4A strains, with (YL1721) or without (YL1722) 
GALS-ESP1 were arrested by incubation in raffinose+methionine medium to deplete 
Cdc20.  Galactose or Galactose+nocodazole+benomyl was added at time zero, 
keeping methionine present to maintain the cdc20 block.  This experiment was 
carried out at 23º. Upper panels show the fraction of large budded cells (without 
rebudding) (left) and the fraction of rebudded cells, i.e. large-budded cells with extra 
small buds attached (right).  Note that these graphs exclude cells produced by normal 
mitotic exit, which are not large-budded and are either unbudded, or contain a small 
bud.  Lower panels show the results of DNA flow cytometry analysis. 
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7. Quantitative measurement of Esp1-induced Cdc14 release 
and activity 
 
The ability of overexpressed Esp1 to promote ME was attributed to its ability to 
promote MEN-independent Cdc14 release from the nucleolus (Sullivan and Uhlmann, 
2003).  It is well established that the activity of Cdc14 is regulated by its localization 
in the nucleolus, where it is stably bound to its inhibitor Net1 and also sequestered 
from many potential dephosphorylation targets.  The MEN is known to drive 
efficient release of Cdc14 from the nucleolus. (Shou et al., 1999; Visintin et al., 1999).  
It is important to note that the release status of Cdc14 is not all-or-none.  The terms 
“partial release” and “full release” have been introduced to qualitatively describe 
Cdc14 localization (Stegmeier et al., 2002).  Here, I use 2-color imaging with 
Cdc14-YFP and Net1-CFP (Pereira et al., 2002) and define a parameter “r” for any 
individual cell based on quantitative fluorescence microscopy.  
the mean intensity of 5% brightest YFP pixels - the mean intensity of 5% dimmest YFP pixels
the mean intensity of 5% brightest CFP pixels - the mean intensity of 5% dimmest CFP pixels
r =  
This value will be high when Cdc14-YFP and Net1-CFP are colocalized, and low 
when Cdc14-YFP is significantly more dispersed than Net1-CFP (which is thought to 
remain nucleolar throughout the cell cycle).  Thus, a lower r value should indicate 
higher Cdc14 release from Net1, and consequently increased Cdc14 activity.  To 
establish the validity of this approach, I measured r throughout a cdc20 block-release 
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experiment.  At 30 minutes post release, cells with low r values appear exclusively in 
the anaphase subpopulation.  10 minutes later, Cdc14-YFP is resequestered into the 
nucleolus as the low-r fraction diminishes (Figure 3.10A).  Thus, the r statistic 
clearly reflects the known dynamic localization behavior of Cdc14.  (It is notable in 
these images that I essentially never observe complete absence of Cdc14 from the 
nucleolus; corresponding to this, the r value is never below ~0.3 in this experiment, 





Figure 3.10.  Quantitative measurement of Cdc14 release.  A. A MET3-CDC20 
CDC14-YFP NET1-CFP strain (YL1452) was arrested in metaphase by incubation in 
+Met medium, and released at time zero by removal of Met. The “r” value 
(characterizing the degree of cellular dispersion of Cdc14 relative to Net1) for cells at 
various time-points was determined as described in Materials and Methods. Yellow 
curve: r value distribution in anaphase subpopulation. Green curve: r value 
distribution in unbudded/small-budded/rebudded cells. Red curve: r distribution in 
metaphase subpopulation.  X axis is the r value; Y axis is frequency.  The red, green 
and yellow distributions sum to the total histogram of r values (bars).  Arrowhead on 
the picture highlights the bud-neck localization of Cdc14-YFP at ME. White numbers 
indicate r values for specific representative cells. Scale bar: 10 microns. In this and all 
the following experiments involving r value measurement, at least 50 cells were used 
to generate the distribution for each category at each time point. B. A MET3-CDC20 
6xGAL1-ESP1 strain (YL1451) was arrested in metaphase by incubation in +Met 
medium. Galactose (G) or Raffinose (R) were added at time zero in the presence 
(+NOC) or absence (-NOC) of nocodazole + benomyl (methionine was kept in the 
medium throughout to maintain Cdc20 depletion).  At the indicated times, r values 







I then examined the ability of overexpressed Esp1 to drive Cdc14 release from 
the nucleolus in cdc20-blocked cells, with or without spindle depolymerization 
induced by nocodazole. In these experiments, I used 6xGAL1-ESP1 (Sullivan and 
Uhlmann, 2003) instead of GALS-ESP1 because the higher overexpression produced a 
stronger and more synchronous phenotype. (Qualitatively similar results were also 
obtained with GALS-ESP1).  I observe Cdc14 release (low r value cells) in 
Esp1-overexpressing cells undergoing spindle elongation and anaphase; strikingly, 
addition of nocodazole blocked Cdc14 release measured by this assay (Figure 3.10B)  
 
I have quantified Cdc14 release in CDC15 or cdc15-2 cells, both MET3-CDC20, 
released from a cdc20 block at 37° to inactivate cdc15-2.  Upon release, r shifted 
strongly and transiently to a low value 20 minutes after release in the CDC15 control.  
In contrast, I observed only a slight decrease in r in the cdc15-2 cells; this decrease 
was maximal at 20 minutes after release.  Some Cdc14-YFP speckles outside the 
nucleolus are observed in cdc15-2 cells, but are largely absent in the CDC15-wt 
control (Figure 3.11); I do not know what these signify.  Any MEN-independent 
Cdc14 release is apparently described by the small but reproducible decrease in r at 20 
minutes after release, and the occurrence of the Cdc14-YFP speckles.  Thus, Cdc14 
release driven by the MEN is qualitatively and quantitatively stronger in my 






Figure 3.11.  (Left). MET-CDC20 CDC14-YFP NET1-CFP strains, either CDC15 
(YL1361) or cdc15-2 (YL1362) were arrested in metaphase by incubation in 
methionine-containing medium to deplete Cdc20, then released into methionine-free 
media at 37° to inactivate cdc15-2.  Samples were taken every 10 minutes, the cells 
were briefly fixed and quantitative fluorescence microscopy (see Materials and 
Methods) was used to calculate the r value for individual cells. The colored lines 
represent histograms of cells at each r value, with the morphology indicated in the 
cartoons below, based on Net1-CFP staining. The bars represent the complete 
histogram of r values (sum of the colored lines). Right: Sample pictures at indicated 











I conclude that separase Esp1 promotes ME in cdc20-blocked cells primarily via 
cohesin cleavage and consequent spindle elongation, rather than by a 
cohesin-cleavage-independent function of Esp1.  The experiments described above 
implicate MEN activation as the proximal target of spindle elongation, resulting in 
effective Cdc14 release to drive ME. 
 
A high level of CDK activity was shown to induce Cdc15 phosphorylation and 
lower Dbf2 kinase activity, and these reactions could have the potential to impair 
Cdc14 release (Jaspersen and Morgan, 2000; Menssen et al., 2001; Stegmeier et al., 
2002).  I were concerned, therefore, that my experimental manipulation of blocking 
Cdk inactivation was not truly independent of promotion or prevention of Cdc14 
release.  To investigate this, I quantified the release kinetics of Cdc14 in the presence 
of undegradable Clb2 (Clb2-kd, lacking the KEN boxes and destruction box.  
CLB2-kd at its endogenous locus is lethal, but can be rescued by Sic1 overexpression 
from the GAL1 promoter (Wasch and Cross, 2002); GAL1-SIC1 turnoff in this strain 
results in a block to ME (Wasch and Cross, 2002)).  I synchronized a GAL1-SIC1 
CLB2-kd CDC14-YFP NET1-CFP MYO1-mCherry strain in G1 with alpha factor, and 
released into glucose to shut off Sic1 expression, or into galactose as a control. 
Cell-cycle progression was monitored by budding, Myo1-mCherry to mark the bud 
neck and cytokinesis (Bi et al., 1998) and the separation of the Net1-CFP signal 
across the bud neck was monitored to assay anaphase.  Clb2kd cells arrest in 
telophase as described (Wasch and Cross, 2002), but Cdc14 release was very efficient, 
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essentially coincident with anaphase and then persisting for about 30 minutes (Figure 
3.12A).  This result essentially confirms a previous finding of Cdc14 release in the 
presence of undegradable Clb2 (Stegmeier et al., 2002), obtained using CLB2-db 





Figure 3.12.  Cdc14 release occurs despite persistent endogenous Clb-Cdk 
activity.  A: Strain CLB2,kd GAL1-SIC1 CDC14-YFP NET1-CFP MYO1-mCherry 
(ALG611) was arrested in alpha factor in galactose media, then released into either 
glucose to turn off GAL1-SIC1 (Glu) or galactose media (Gal) to keep GAL1-SIC1 on. 
Cdc14 localization was quantified as in Fig. 3.10.  DNA flow cytometry, Clb2 
western blot and r value test were performed as described in Materials and Methods. 
The inset cartoon shows the cell morphology of each category.  B. MET3-CDC20 
cdh1Δ GALS-ESP1 (YL165) cells were first arrested in metaphase by incubation in 
raffinose plus methionine medium, then galactose plus methionine was added to 
induce Esp1 overexpression at time zero. DNA flow cytometry, Clb2 western blot and 
r value test were performed as described in Materials and Methods. 
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In a different experimental approach to the same question, I assayed GALS-ESP1 
induction of ME in cdc20-blocked cells (as in Figure 3.7A), in the absence of CDH1.  
These cells lack any factor to activate the APC for Clb degradation, since at least one 
of either Cdc20 or Cdh1 is required for Clb degradation (Wasch and Cross, 2002).  
Unlike CDH1 controls (Figure 3.7A), the cdh1 cells maintained a stable telophase 
block without any evidence of ME in this protocol, for up to four hours (when some 
degree of rebudding occurs).  Despite this stable block, very efficient Cdc14 release 
was observed throughout this period (Figure 3.12B).  
 
These results show that stabilized Clb cyclins cannot block Cdc14 release when 
expressed at endogenous levels.  Therefore spindle elongation is likely to be the 
primary mechanism driving full Cdc14 release, rather than a separase-dependent but 
cohesin cleavage-independent mechanism, such as a Cdc14-Cdc15 positive feedback 
triggered by Esp1 (Queralt et al., 2006). 
 
The experiments in Figures 3.7 and 3.12 allow me to propose a model for 
induction of ME by ESP1 overexpression in cdc20-blocked cells: the overexpressed 
Esp1 cleaves cohesin and allows spindle elongation, prompting MEN activation when 
the daughter spindle pole reaches the bud cortex (Bardin et al., 2000; Yeh et al., 1995).  
MEN activation promotes Cdc14 release, which can activate Cdh1 by 
dephosphorylation (Zachariae et al., 1998), leading to Clb degradation.  My results 
with nocodazole, cdc15-2, and cdh1 suggest that all of these steps are required for 
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overexpressed Esp1 to induce effective ME.  
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8. Mitotic exit network controls Cdc14 nuclear export 
 
Net1 sequestration in the nucleolus is the only characterized mechanism for 
regulation of Cdc14 activity; hence net1 deletion would be expected to completely 
relieve any MEN-dependent regulation of Cdc14.  However, I were surprised to find 
that in net1Δ cells, Cdc14-YFP localization is still cell-cycle regulated, being 
concentrated in the nucleus for most of the cell cycle, but spread throughout the cell 
transiently at ME (Figure 3.13B). 
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Figure 3.13.  Mitotic Exit Network controls Cdc14 nuclear export.  A. WT and 
net1Δ cells containing CDC14-YFP (YL1701) were briefly fixed and stained with 
DAPI to label DNA (top); net1 CDC14-YFP strains containing NOP1-dsRed (YL1702) 
or dsRed-NLS (YL174) were examined separately.  B. Selected frames of a 
time-lapse movie (Bean et al., 2006) with indicated strain genotypes. In net1Δ 
CDC14-YFP (YL1701) cells, Cdc14-YFP was transiently excluded from the nucleus 
approximately at the time of ME. This transient nuclear exclusion was not observed in 
net1Δ CDC14-YFP cdc15-2 (YL161) cells at 37°C.  C. The percentage of cell cycles, 
tracked using fluorescent time-lapse microscopy, in the course of which Cdc14-YFP 
release from nucleus was observed.  50 cell cycles were examined in each condition.  
D. Quantification of Cdc14 release from nucleus in a net1Δ background. The 
coefficient of variation (CV) of Cdc14-YFP signal inside a single cell, computed from 
fluorescent time-lapse microscopy data, is the standard deviation of YFP pixel 
intensity across the cell, divided by the mean intensity; this number will be high in 
cells with Cdc14-YFP concentrated in specific regions, and low when Cdc14-YFP is 
dispersed through the cell.  Four examples of CDC15-wt (blue) and cdc15-2 (red) 
cells, both at 37°, are shown. Curves are aligned by nuclear division as judged by 
initial stretching of the Cdc14-YFP signal across the bud neck, at t=0. Color bars 











To examine the possibility that this result is due to residual binding of Cdc14 to 
other nucleolar components, I examined colocalization of Cdc14-YFP with DNA, 
with the nucleolar marker Nop1-dsRed (Gadal et al., 2001), and with a general marker 
of nuclear volume, dsRed-NLS (Rodrigues et al., 2001).  In NET1 cells, Cdc14 is in 
a typical crescent-shaped nucleolar distribution flanking the bulk of nuclear DNA, 
while in net1 cells, Cdc14-YFP staining is enlarged to contain the DNA signal.  In 
net1 cells, Cdc14-YFP is localized much more broadly than the Nop1-DsRed 
nucleolar marker, but is coincident with the dsRed-NLS marker for the nuclear 
interior.   Thus, in net1 cells, Cdc14 is not retained in the nucleolus but is 
nevertheless restricted to the nucleus (Figure 3.13A), through most of the cell cycle.  
 
I used time-lapse fluorescence microscopy to study whether the MEN is 
responsible for Cdc14 nuclear export in the absence of Net1. When the MEN is 
inactivated at restrictive temperature in a cdc15-2 net1Δ strain, Cdc14-YFP remains 
concentrated in the nucleus throughout the cell cycle, in contrast to CDC15 net1Δ 
cells with an intact MEN (Figure 3.13B,C).  (Note that the net1 deletion bypasses the 
cdc15 block to telophase exit, as expected (Shou et al., 1999)).  The Cdc14 nuclear 
export phenotype can be quantified using time-lapse microscopy to calculate the 
dispersion of Cdc14-YFP signal inside individual cells.  A decrease of CV 
(Coefficient of Variation) corresponds to Cdc14 nuclear export (because Cdc14 is no 
longer concentrated, therefore the signal across the cell is less variable). A drop in the 
CV for Cdc14-YFP is clearly detected in CDC15 cells at low and high temperatures, 
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but absent in cdc15-2 cells specifically at 37° (Figure 3.13D).  CDK activity by itself 
is unlikely to control Cdc14 export, since the timing of Clb2 degradation in cdc15-2 
net1Δ is almost identical to CDC15 net1Δ (Figure 3.14) as expected (Shou et al., 
1999).  Cdc14 nuclear export is probably not directly driven by Esp1 activity, 
because the timing of this Cdc14 nuclear export correlates with ME rather than 
anaphase (which is directly promoted by Esp1 activity), and because Cdc14 nuclear 
export is impaired in net1Δ cdc15-2 cells where Esp1 activity is presumably normal.  
Consistent with my observation, a nuclear export sequence in yeast Cdc14 has been 
reported.  Mutations of that sequence cause Cdc14 to fail to localize to the bud neck 
during mitotic exit (Bembenek et al., 2005).  Functions of the Cdc14 nuclear export 
signal may be tied to MEN activation. 
 
These observations implicate the MEN in a previously unsuspected aspect of 
Cdc14 activation: its release from the nucleus and dispersal throughout the cell.  This 
activity may contribute to the ability of the MEN, but not FEAR- or Esp1-induced 
Cdc14 release, to promote complete mitotic exit.  A recent publication showing that 
the MEN component Dbf2 is involved in Cdc14 nuclear export, independent of its 






Figure 3.14.  net1∆ bypasses the MEN requirement for Clb2 degradation but not 
for cytokinesis. net1∆ cdc15-2 (YL1541) or net1∆ CDC15 (YL1542) strains were 
arrested in alpha factor at 27˚. At time zero, the cultures were released by removal of 
alpha factor.  Release was at 37˚ to inactivate cdc15-2. Alpha factor was added back 
at 100 minutes to prevent cells from entering the next cell cycle. Cytokinesis was 
assessed by the occurrence of a 1C DNA peak in DNA flow cytometry profile.  Clb2 
degradation was assessed by Western blot and quantified relative to a control Western 
blot of Pgk1. 
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9. Clb-Cdk activity may cooperate with Cdh1 to prevent 
Cdc14 from returning into the nucleolus  
  
 I demonstrated that Esp1 overexpression induced long-term release (~3 hours) of 
Cdc14-YFP in cdc20- cdh1- cells (Figure 3.12B).  Since Cdc14 release normally 
only lasts for 15~20 minutes, it is interesting to know which factor prevents Cdc14 
from returning into nucleolus in this condition.  
 
 In cdc20- CDH1+ cells, Esp1 overexpression induces Cdc14 release of normal 
duration (~20 minutes), which leads to mitotic cyclin-Cdk inactivation and ME events 
(Figure 3.10B).  Addition of NOC to the medium prevents induction of Cdc14 
release and cyclin-Cdk degradation by Esp1 overexpression (Figure 3.7A, 3.10B).  
Therefore, the spindle could serve as a signaling center to sustain Cdc14 release status 
until its disassembly at ME.  Alternatively, Cdc14 release could also be sustained by 
Clb-Cdk activity.  To test those hypothesis, MET-CDC20 cdh1 cells were blocked by 
depleting Cdc20, and Esp1 was overexpressed from GALS promoter at t=0.  After 90 
minutes when >95% cells had went through anaphase and released Cdc14, the culture 
was split into two.  NOC was added into one culture to disassemble spindle, and 
Cdc20 was re-induced in the other culture to degrade mitotic cyclins.  ME events 
and Cdc14 release were monitored during the time-course.  In cdc20- cdh1- cells, 
NOC did not cause also any appreciable changes to either Cdc14 release or rebudding 
kinetics compared with NOC-free culture (Figure 3.15A, Figure 3.12B).  In the 
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culture where Cdc20 was re-induced at 90 minutes, I initially observed a further 
release of Cdc14-YFP at 115 minutes reflected as a lower-shift of the r-value 
distribution.  Then, Cdc14 rapidly returned into nucleolus (Figure 3.15A).  Since 
Cdc20 re-induction causes mitotic cyclin inactivation, mitotic cyclin-Cdk activity may 
prevent Cdc14 from returning into nucleolus in cdc20- cdh1- cells.  In this 
experiment, I observed that Cdc14 release by Esp1 overexpression in cdc20- cdh1- 
cells was quantitatively incomplete.  I compared the pictures from maximum 
Cdc14-release time point in CDH1+ and cdh1- cells, induced by Esp1 overexpression.  
Cdc14-YFP localization appeared to be more nuclear concentrated in cdh1- cells 
(Figure 3.15B). (Note: even in control experiments, I never observe complete Cdc14 
release from the nucleolus; there is usually a weak Cdc14-YFP signal in the nucleolus 
even if Cdc14 release already reached its maximum by quantification.) cdc20- pds1Δ 
cells can achieve a similar telophase arrest with high mitotic cyclins and released 
Cdc14 (Shirayama et al., 1999) without Esp1 overexpression.  In those cells, 
Cdc14-YFP localization also appeared to be nuclear concentrated (Figure 3.15B).  
Therefore, mitotic cyclin-Cdk activity could retain Cdc14 in the nucleus and prevent 
Cdc14 from returning into nucleolus, which potentially explains why the FEAR 
network-induced Cdc14 tends to regulate events in the nucleus (such rDNA 
segregation, spindle elongation), but does not induce cytokinesis.  The relationship 
between this nuclear concentration of Cdc14, induced by mitotic cyclin-Cdk, and the 
MEN-induced nuclear exit of Cdc14 (even after nucleolar exit) documented in the 





Figure 3.15.  A. Strain MET-CDC20 cdh1∆ GALS-ESP1 was grown in raffinose 
medium and blocked with cdc20- by adding methionine to the culture. 90 minutes 
after GALS-ESP1 induction at t=0, the culture was split into two.  NOC was added to 
one culture (left), and Cdc20 was reinduced in the other culture by washing away 
methionine (right).  Samples were taken at indicated time points, and Cdc14 
localization was analyzed as described in Materials and Methods.  Bar plot: r value 
distribution for the entire population.  Red/green/blue/purple curve: r value 
distribution for metaphase/anaphase/rebudded/small-budded subpopulations.  B. 
MET-CDC20, MET-CDC20 cdh1∆ GALS-ESP1, and cdc20::GALL-CDC20 pds1∆ 
strains, containing CDC14-YFP NET1-CFP were blocked with cdc20-.  
MET-CDC20 cells were released into cell cycle progression by washing away 
methionine, and the picture showing Cdc14 release was taken at 30 minutes after 
release. Galactose was adding to MET-CDC20 cdh1∆ GALS-ESP1 cell culture to 
overexpress Esp1, and the picture was taken 2 hours later. The cdc20::GALL-CDC20 
pds1∆ picture was taken 4 hours after adding glucose in the culture to turn off the 











10. Spindle checkpoint inactivation by FEAR-induced Cdc14 
release 
 
 I showed in Figure 3.7A that Esp1 ovexpression did not induce ME or Clb2 
degradation in cdc20- cells with NOC added.  However, it is known that Esp1 
overexpression induces efficient Clb2 and Pds1 degradation in NOC arrested cells 
(with Cdc20p present, but presumably inhibited by the spindle 
checkpoint)(Tinker-Kulberg and Morgan, 1999), suggesting that Esp1 overexpression 
can inactivate spindle checkpoint in NOC, likely through releasing Cdc14.  
 
   If FEAR-released Cdc14 can activate Cdc20 to degrade Pds1 and release 
inhibition of Esp1, Esp1 will cause more Cdc14 release by activating FEAR network, 
potentially forming a positive feedback loop to accelerate cell cycle recovery from 
spindle checkpoint arrest.  I tested this idea by comparing Pds1p degradation kinetics 
in slk19, cdc14-1, esp1-1, and esp1-1 ESP1C1531A cells following release from NOC 
arrest.  Consistently, I found that Pds1p degradation was delayed in both slk19Δ and 
cdc14-1 cells by 10~15 minutes, compared with WT cells (Figure 3.16).  But 
interestingly, Pds1 degradation was not affect by the non-proteolytic function of Esp1.  
In a recent publication, Cdc14 is shown involved in a positive feedback loop with 
Cdc20 to achieve a coherent metaphase-anaphase transition(Holt et al., 2008); the 
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involvement of Esp1 (with or without its proteolytic activity) was not addressed in 
this publication, but the work is still consistent with the idea proposed above that 






Figure 3.16.  slk19∆, esp1-1, esp1-1 ESP1C1531A, cdc14-1 and wild-type cultures 
were arrested in glucose medium + NOC +BEN at 25℃ as described in Materials and 
Methods. Then, temperature was shifted to 37℃ to inhibit temperature-sensitive 
alleles, and the cultures were released into cell cycle by washing away NOC+BEN, 
still at 37℃. Protein samples were taken at indicated time points to analyze 






In budding yeast, Cdc14 is absolutely required for ME, and much evidence 
indicates that Cdc14 can not promote ME until it is released from its nucleolar anchor 
Net1.  My results in this chapter show that efficient ME requires CDK inactivation 
and spindle elongation driving MEN activation, but Esp1 is not required beyond the 
need for cohesin cleavage.  Furthermore, I devised a quantitative method to measure 
Cdc14 activity, which revealed that Cdc14 release driven by Esp1 overexpression 
depends on spindle elongation and MEN activation.  My conclusion is consistent 
with previous findings that the FEAR network is dispensable for the cell cycle, while 
MEN activation is essential for effective release of Cdc14 from Net1 (Hofken and 
Schiebel, 2002; Shou et al., 1999; Stegmeier et al., 2002; Visintin et al., 1999).  
Interestingly, separase is also not required for ME in mammalian cells or fission yeast 
(Hirano et al., 1986; Wirth et al., 2006) 
 
An absolute requirement for Esp1 in ME was supported by the finding that Esp1 
overexpression, rather than TEV-protease induced spindle elongation, triggered ME 
(Sullivan and Uhlmann, 2003).   These results, which I have confirmed (data not 
shown), were obtained in a cdc20-deficient background, and I interpret the apparent 
Esp1 requirement to be due to high Clb-Cdk activity levels because of Cdc20 
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depletion.  In my experiments where anaphase is promoted by TEV protease or by 
mutational inactivation of cohesin, ME can occur in the absence of Esp1 activity if 
Cdc20p is kept active (allowing mitotic cyclin degradation), or if Clb-Cdk activity is 
inhibited by GAL1-SIC1-4A.  In the presence of high Clb-Cdk levels, TEV protease 
may promote transient spindle elongation which only partially activates MEN, 
causing failure to exit from mitosis in cdc20 arrest (Higuchi and Uhlmann, 2005).  
 
The requirement for inactivation of Clb-Cdk1 activity before ME places 
APC-Cdc20 in a uniquely important position in the ME control system.  Mitotic 
cyclin degradation in budding yeast is biphasic (Yeong et al., 2000).  APC-Cdc20 
degrades Clb5,6 and partially degrades Clb1,2 at the metaphase to anaphase transition, 
which may lower the overall Cdk activity level sufficiently to allow ME, once the 
MEN is triggered by spindle elongation.  Consistently, deleting CLB5 to lower 
Clb-Cdk activity can restore viability to cdc20Δ pds1Δ strains (Shirayama et al., 1999).  
Thus, the stable arrest observed in cdc20 cells cannot be overcome simply by 
allowing Esp1 to escape from Pds1 inhibition (either by pds1 deletion or by ESP1 
overexpression); Cdk inactivation is independently required, and is provided in the 
first phase of Clb degradation in the wild-type system by Cdc20.  Cdc20 is even 
required to recover from cdc15-2 arrest (Yeong et al., 2000).  A likely explanation is 
that depletion of Cdc20 during a cdc15-2 arrest increases the Clb cyclin level, making 
the cell unable to recover from telophase arrest after being shifted to permissive 
temperature.  The mechanism by which Clb-Cdk inhibits ME is unknown.  High 
92
Clb-Cdk may block cytokinesis and rebudding directly (Eluere et al., 2007; 
Padmashree and Surana, 2001).  These results thus suggest that Esp1 is not sufficient 
to drive ME, even when overexpressed.  
 
The esp1-2td allele is thought to completely remove separase activity (Queralt et 
al., 2006).  In my hands this allele only causes a 2 hour delay in ME (data not 
shown), confirming recent results (Visintin et al., 2008).  These results support my 
conclusions derived using Pds1 as an Esp1 inhibitor (see above) in suggesting that 
Esp1 is not necessary for ME.  Its absence does clearly delay ME very significantly, 
but I suggest that most or all of this delay is due to failure of cohesin cleavage, which 
prevents spindle elongation, greatly delaying MEN activation and Cdc14 release.  It 
is clear from much work that Cdc14 release is essential for ME. 
 
Cdc14 release is thought to be biphasic: Esp1 induces the FEAR network, 
promoting the first wave of Cdc14 release in early anaphase.  ME is delayed until the 
second wave of Cdc14 release, promoted by the MEN; the reason for this delay is 
unknown.  My quantification of Cdc14 release suggest that Esp1 and the FEAR 
pathway, in the absence of spindle elongation or MEN activity, do not promote a 
quantitatively or qualitatively sufficient degree of Cdc14 release to trigger ME. 
Esp1-induced Cdc14 release has been reported to fulfill ME-independent functions, 
such as stabilizing the anaphase spindle (Jensen et al., 2001).  The functional 
diversification of Cdc14 at early and late anaphase might in part be due to the ability 
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of MEN to control Cdc14 nuclear export, independent of its restriction to the 
nucleolus; nuclear export could allow access of Cdc14 phosphatase to additional 
substrates. Consistently, in net1Δ cells, the bud-neck localization of Cdc14-YFP only 
appears at ME when the MEN is activated and Cdc14 release from the nucleus is 
promoted.  I do not observe bud-neck localization of Cdc14 upon ESP1 
over-expression, if spindle elongation is inhibited by nocodazole (Figure 3.10B).  
Intact microtubules are not likely to be intrinsically required for ME or Cdc14 release, 
since in a mad2 bub2 double mutant, lacking all known spindle surveillance pathways, 
microtubule depolymerization with nocodazole has no effect on the kinetics of Clb2 
degradation, rebudding and DNA replication in the subsequent cell cycle (Alexandru 
et al., 1999), strongly suggesting that Cdc14 phosphatase was properly released and 
activated at ME in this context.  I cannot completely exclude the possibility that the 
FEAR network could require an intact spindle to function for reasons unrelated to 
ultimate spindle elongation.  However, my conclusions are consistent with the 
finding that both Cdc14 release and ME (assessed by spindle disassembly) in the 
dyn1Δ mutant coincide with SPB moving into the bud, rather than spindle elongation 
per se (i.e. separase activation) which frequently happens within the mother cell body 
in this mutant (Bardin et al., 2000).  In these cells, the spindle is intact, but Esp1 still 
appears unable to promote ME on its own. 
 
Esp1-induced Cdc14 release was previously reported to occur in nocodazole 
(Visintin et al., 2003).  I observe a spreading of the Cdc14-YFP signal in 
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cdc20-depleted cells after long-term induction of ESP1–overexpressing cells in 
nocodazole, but an essentially identical spreading of Net1-CFP was also observed, 
which colocalized with Cdc14-YFP, accounting for the maintenance of a high r value 
(Figure 3.10B).  I do not know whether this spreading is due to the release of Net1 as 
well as Cdc14 from the nucleolus, or to a general disruption of nucleolar structure.  
The tight colocalization suggests that Net1 has the potential to bind and inactivate 
Cdc14 in this condition, which could explain the lack of mitotic exit in this context.  
Deletion of CDC55 has been reported to hyper-activate the FEAR network and cause 
constitutive Cdc14 release in cdc20-blocked cells (Queralt et al., 2006).  I observed 
essentially the same scenario of co-spreading of both Cdc14-YFP and Net1-CFP in 
cdc20- blocked cdc55Δ cells (data not shown). 
 
ME is a complex system, governed by an interdigitated control network.  Here, I 
have attempted to elucidate the system with all major control parameters taken into 
consideration in a balanced way, in order to gain an understanding of the relative 
importance of various pathways in controlling ME.  My results lead to the 
conclusion that Cdk inactivation is absolutely required for ME.  In my analysis, Esp1 
does not make a quantitatively major contribution to kinetics of ME beyond that due 
to its ability to cleave cohesin.  Cohesin cleavage and consequent spindle elongation 




12. Remaining issues from my experiments: 
 
 1. How is the MEN activated?  The prevailing model is that spindle elongation 
pushes one SPB close to the bud cortex where Lte1 localizes.  Lte1 can activate 
GTPase Tem1 probably as its guanine exchange factor to induce the 
Tem1-Cdc15-Dbf1 signaling cascade.  However, Let1 is not essential for cell 
viability.  There should be parallel mechanisms activating MEN by sensing anaphase.  
It is also unclear whether SPB has to directly contact the bud cortex to activate MEN, 
or just needs to get close to it.  It has been reported that some proteins (like Kar9 and 
Bim1) can travel along cytoplasmic microtubules.  It is imaginable that cell 
polarization proteins (like Cdc42, Lte1, Ste20 et al.) might reach the SPB by traveling 
along microtubules to activate Tem1 at the SPB. 
 
2. Does Cdc14 localize differently in early and late mitosis in normal cell cycles?  
My data and previous publications suggested that Cdc14 might localize in 
nucleus/spindle in early mitosis, and switch to cytoplasm and bud-neck in later 
mitosis. However, most experiments were performed with the cell cycle blocked by 
various means.  It is important to know whether Cdc14 localization really follows 
this rule in normal cell cycles. 
 
3. What causes Cdc14 to return into nucleolus?  Although Cdc5 degradation by 
Cdh1 has been reported to promote Cdc14 re-sequestration, in cycling cdh1Δ cells, 
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Cdc14 resequestration was delayed by at most 3 minutes (i.e., any difference is at 
frame resolution) in my single cell time-lapse analysis.  So there must be parallel 
mechanisms promoting Cdc14 resequestration.  Since both polo kinase and the MEN 
are essential for Cdc14 release, inactivation of MEN may lead to Cdc14 
re-sequestration.  My data showed that in the absence of Cdh1, mitotic cyclin-Cdk 
activity can maintain Cdc14 in released state for 3 hours, indicating Clb-Cdk may 
prevent MEN inactivation.  It is unclear how the MEN is inactivated at the end of 
mitosis.  Cdc14 has been shown to dephosphorylate Bub2 to inactive the MEN.  
The MEN could also be inactivated directly due to budding which translocates MEN 
activators into the incipient bud.  Cdc14 can promote Lte1 delocalization from bud 
cortex into cytoplasm at least under overexpression, pointing to another possible way 
for MEN inactivation by Cdc14, though the causal relationship has yet to be 
demonstrated.   
 
One problem that makes it difficult to reason effectively on these issues is that it 
remains unclear how the MEN and the FEAR network release Cdc14 from nucleolus.  
One model suggests that Dbf2, Cdc5 and Cdk can phosphorylate Net1 and Cdc14 to 
promote their disassociation, but solid evidence is still missing.  Effective Cdc14 
release could be coupled directly to nucleolar division, providing a direct cell 
biological coupling between anaphase and ME.  This model could explain the 
requirement I observed for intact microtubules for promotion of Cdc14 release by 
Esp1. 
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4. Cdc14 released by FEAR network has been shown to promote rDNA 
segregation.  In my experiments, Clb2kd expression can delay rDNA segregation, 
but not bulk DNA segregation, in single cell analysis.  Therefore, 
phosphorylation/dephosphorylation may be a way to coordinate rDNA segregation 
with anaphase, but the potential Cdk/Cdc14 targets are unknown. 
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Chapter 4: Cell Cycle Control by 
Phase-Locking: Study of the Cdc14 Release 
Endocycle 
1. Background information 
 
The eukaryotic cell cycle is driven by oscillations in levels and activity of 
cyclin-dependent kinase (Cdk) (Morgan, 2007).  These oscillations are accompanied 
by ordered progression of cell cycle events.  There are at least two mechanisms to 
ensure correct ordering of these events.  Checkpoint surveillance mechanisms delay 
subsequent events until previous ones are finished (Elledge, 1996; Weinert et al., 
1994).  However, checkpoints are dispensable for correct ordering of cell cycle 
events, at least in budding yeast. 
 
Order can be established independent of checkpoints by a ‘ratchet’-like 
mechanism under direct control of cyclin-Cdk oscillations: initiation of an event is 
triggered by high cyclin-Cdk, but completion of the event is inhibited by high 
cyclin-Cdk (Nasmyth, 1996; Stern and Nurse, 1996).  The consequence of this 
regulation is that cell cycle events occur exactly once per cyclin-Cdk cycle in a 
regular sequence.  There is abundant evidence for this mechanism in control of DNA 
replication (Kearsey and Cotterill, 2003).  Division of regulatory function among 
multiple cyclins complicates this simple picture; nevertheless, a generally similar 
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ratchet-like mechanism may apply to many cell cycle processes, such as spindle and 
bud morphogenesis (Bloom and Cross, 2007).   
 
Ratchet control can be attained by many molecular mechanisms.  For the 
proposed ratchet control of DNA replication, many different redundant mechanisms 
coexist in any given species, and very different mechanisms can operate in different 
species (Kearsey and Cotterill, 2003).  Nevertheless, all ratchet mechanisms, 
controlling any cell cycle process, have one unavoidable prediction: blocking the 
cyclin-Cdk cycle by locking Cdk activity at any constant level should arrest a 
ratchet-controlled process at a single defined step in its trajectory.  The 
dose-response of where the process arrests in response to cyclin-Cdk level is then 
informative as to mechanism and the overall structure of the control system. 
 
Some cell cycle events may occur cyclically and repetitively in the likely absence 
of oscillation of mitotic cyclin-Cdk activity.  Examples include the SPB/centrosome 
duplication cycles in budding yeast and various animal embryos, and the periodic 
budding and cell-cycle-regulated transcription in budding yeast.  These 
‘endocyclical’ events are not likely driven by oscillations of other cyclins (Gard et al., 
1990; Haase and Reed, 1999; Haase et al., 2001; McCleland and O'Farrell, 2008; 
Sluder et al., 1990).  DNA endoreduplication could also be considered under this 
category since it occurs in the absence of mitotic B-cyclin activity.  However, in this 
case, a ratchet-like mechanism driven by other cyclins such as cyclin E has been 
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proposed (Inze and De Veylder, 2006; Weiss et al., 1998).  
 
On their face, these endocycles pose a significant challenge to the concept of 
cyclin-Cdk-based ratchet control.  However, the relevance of these endocycles to the 
mitotic cell cycle, and what mechanism, if any, entrains them to mitotic cyclin-Cdk 
cycles, remains unclear (Murray and Kirschner, 1989).  
 
Recently, we carried out an analysis of dose-response of mitotic exit to locked 
cyclin-Cdk activity levels, using titrated pulses of undegradable mitotic cyclin Clb2 
and correlating steps of mitotic exit to Clb2 levels in individual cells (Drapkin et al., 
in press).  High Clb2 levels have long been known to block mitotic exit (Surana et al., 
1993); however, we found that the peak level of Clb2-Cdk activity attained in a 
normal cell cycle was inefficient at restraining multiple aspects of mitotic exit.  
These results strongly suggested that the simple cyclin-based ratchet model accounted 
poorly for control of mitotic exit, and a better fit was obtained by incorporating the 
activity of Cdc14 phosphatase as a general cyclin-Cdk antagonist, capable of 
dephosphorylating multiple cyclin-Cdk phosphorylation targets.  (This specificity is 
consistent with structure and in vitro activity of Cdc14 (Gray et al., 2003)). 
 
Effective regulation of Cdc14 localization and activity is probably essential for 
normal cell cycle progression.  Cdc14 is restrained and inhibited in the nucleolus by 
the constitutively nucleolar Net1 protein, except in mitosis (Shou et al., 1999; Visintin 
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et al., 1999).  The spindle orientation checkpoint (SPOC, regulating the mitotic exit 
network MEN) is an important regulator of Cdc14 release (Bardin et al., 2000; Pereira 
et al., 2000; Stegmeier and Amon, 2004).  Anaphase sends the daughter-oriented 
spindle pole body (SPB) into the bud, activating the Tem1-Cdc15-Dbf2 MEN cascade 
which promotes Cdc14 release and activation (Bardin et al., 2000).  However, 
removing the key SPOC inhibitor Bub2 has almost no effect on Cdc14 release in an 
unperturbed cell cycle (data not shown), despite strong deregulation of SPOC function, 
indicating the need for additional mechanisms to account for regulation of Cdc14 
release, which is likely associated with cyclin-Cdk oscillations.  Although 
connections between Cdc14 release and Clb-Cdk activity have been described 
(Azzam et al., 2004; Jaspersen and Morgan, 2000; Queralt et al., 2006; Stegmeier et 
al., 2002), it is as yet unclear how Cdc14 localization responses to difference Clb 
levels and whether these controls constitute a ratchet mechanism sufficient to lock 
Cdc14 release to once per cell cycle. 
 
In this work, I aim to understand how cyclin-Cdk activity controls Cdc14 
localization and activity, and whether this control constitutes a ‘ratchet’ mechanism.  
In initial experiments, I treated the Cdc14 control system as a ‘black box’, and to 
study its input (cyclin-Cdk) – output (Cdc14 localization) relationship at various 
mitotic cyclin levels.  Again, I used pulses of undegradable mitotic cyclin Clb2.  As 
noted above, for a process under cyclin-Cdk ratchet control, this approach is predicted 
to result in arrest of the process at a specific step defined by the locked cyclin-Cdk 
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levels.  In exact contrast to this prediction, though, I observed Cdc14 cycling in and 
out of the nucleolus multiple times at high but physiological fixed mitotic cyclin 
levels.  
 
These observations, along with other cell cycle endocycles reported previously 
(see above), suggest that many cell cycle events have intrinsic ‘clocks’ controlling 
their occurrence.  This concept stands in sharp contrast to the cyclin-Cdk-ratchet 
model, and pose the question of how these events occur only once per Clb-Cdk cycle 
and in a very specific sequence despite the ability to oscillate autonomously. 
 
Based on my study of Cdc14 endocycles, I propose that the cyclin-Cdk oscillator 
entrains (‘phase-locks’) other cell cycle oscillators.  Phase-locking is 
well-established for circadian systems (as well as many other biological and physical 
systems) (Glass, 2001).  Extrinsically applied phase locking has been implemented 
experimentally to control the timing of the budding yeast cell cycle (Charvin et al., 
2009).   
 
My experiments and analysis suggest that Cdc14 localization, likely other cell 
cycles events, is controlled by an intrinsically oscillatory module(s).  In wild-type 
cell cycles, cyclin-Cdk oscillations phase-lock those oscillators to once-per-cell-cycle, 
and the Cdk-response properties of those oscillators determine the timing and order of 
downstream cell cycle events.  The phase-locking model reconciles previous 
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observation of autonomous oscillators with once-per-cell-cycle control of multiple 
cell cycle events, and is compatible with experimental results from my study. 
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2. Blocking mitotic exit with undegradable Clb2kd reveals 
Cdc14 release endocycles 
 
Cdc14-release status is not “all or none” but contains intermediate states 
(Stegmeier et al., 2002).  I designed a quantitative, single cell measurement for 
Cdc14 localization based on variation of cellular Cdc14-YFP pixel intensities, 
standardized to variation of nucleolar Net1-mCherry, which is an improved version of 
my previous assay (Lu and Cross, 2009) (this Cdc14 release measure is 
mathematically predicted to vary linearly with the fraction of Cdc14 released into 
cytoplasm, Materials and Methods).  Fig. 4.1A illustrates the measure applied to a 
CDC14-YFP NET1-mCherry cell undergoing a normal Cdc14 release following 
anaphase.  I used Myo1-GFP as a budding and cytokinesis marker (Bi et al., 1998).  
Since the bud-neck region was always manually excluded from quantification, the 






Figure 4.1.  Cyclical Cdc14 release uncoupled from cell cycle progression.  A, B. 
MET3-CDC20 CDC14-YFP NET1-mCherry MYO1-GFP cells were released from a 
MET3-CDC20 block (t=0). Bottom: Cdc14 release was quantified at each time point. 
Triangle: Myo1 ring. Scale bar: 5 microns.  A: control. B. Clb2kd was pulsed for 30 
minutes before release. C. Schematic of procedure for loading cells with 
undegradable Clb2kd (green) before ME. Nucleolus is shown in red.  D. Pulsed 
Clb2kd-GFP was quantified (right column) in units standardized to the peak level of 
Clb2 attained in a normal cell cycle, and Cdc14 release quantified.  Blue bars: 
anaphase (nucleolar separation, marked by Net1-mCherry); Red bars: cytokinesis 
(Myo1 ring disappearance); green bars: bud emergence.  E. CLN2 promoter 
expression during Cdc14 endocycles.  A CLN2pr-GFP-PEST strain was pulsed with 
Clb2kd as in (B) for 35 minutes.  GFP intensities at the first Cdc14 release, 
maximum during endocycles (n=40), and at rebudding in unpulsed control cells 
(P<10-15. Error bars: standard deviation). 
106
I followed a procedure described in ‘Materials and Methods’ to load cells with 
physiological levels of stable Clb2 during a pre-anaphase block, and then release the 
block and examine events of mitotic exit in single cells as a function of Clb2 level.  I 
blocked cells in metaphase by depleting the essential anaphase-promoting complex 
(APC) activator Cdc20, by shutoff of MET3-CDC20 (Sullivan et al., 2001).  Cdc20 
promotes proteolysis of the separase inhibitor Pds1, driving anaphase, and promotes 
initial proteolysis of B-type cyclins (Shirayama et al., 1998; Wäsch and Cross, 2002; 
Yeong et al., 2000) ; later in mitosis and in G1, B-type cyclin proteolysis is 
maintained by the related Cdh1 activator (Schwab et al., 1997).  I transiently pulsed 
these cdc20-blocked metaphase cells with Clb2kd; Clb2kd lacks the Clb2 destruction 
and KEN boxes recognized by Cdh1 and Cdc20, and is therefore almost completely 
stable (Wäsch and Cross, 2002)).  Clb2kd was labeled with GFP to allow single-cell 
quantification of Clb2kd levels.  This procedure yielded a population with variable 
levels of stable Clb2kd-GFP, averaging around the peak Clb2-GFP level in a 
wild-type cell cycle (I refer to this level as ‘1X peak’ Clb2kd; accurate single-cell 
quantification of Clb2kd levels in these units has been documented elsewhere 
[Drapkin et al, in press]).   
 
Re-inducing MET3-CDC20 induced anaphase, which proceeded on schedule 
independent of stable Clb2kd-GFP (data not shown).  Clb2kd-GFP was stable after 
expression, only being slowly diluted with cell growth (Fig. 4.2). Clb2kd-associated 
kinase activity was essentially constant through this protocol (Drapkin et al, in press).  
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I assayed post-anaphase ME events as a function of single-cell Clb2kd-GFP levels 
(Fig. 4.1C), using quantitative time-lapse microscopy.   
 
~1X peak Clb2kd-GFP and above induced dose-dependent delays in cytokinesis 
and bud emergence (Drapkin et al., in press; Fig. 4.3).  In contrast, Cdc14-YFP was 
released from the nucleolus and subsequently resequestered, with essentially normal 
kinetics up to at least 3X peak Clb2kd-GFP concentrations (Fig. 4.1D and Fig. 4.4; 
Drapkin et al., in press).  Strong overexpression of stable Clb2 was shown previously 
to cause extended Cdc14 release.  I confirmed this observation by constitutively 
overexpressing GAL1-CLB2kd in galactose medium, which results in at least 10-fold 
peak Clb2kd levels (Fig. 4.5).  I assume that results at approximately physiological 
Clb2kd levels are more biologically relevant, and I have not pursued the basis for the 
effect of extreme Clb2kd overexpression on Cdc14 release. 
 
Remarkably, cells with moderately more than 1X peak Clb2kd-GFP frequently 
exhibited multiple cycles of Cdc14-YFP release and resequestration, before finally 
undergoing cytokinesis and rebudding (Fig. 4.1B,D).  I call these ‘Cdc14 




Figure 4.2.  Clb2kd-GFP is stable in vivo. GAL1-CLB2kd-GFP was pulsed for 30 
minutes as described in Materials and Methods. The average GFP intensity inside a 
cell was measured, and  ploted in the upper panel. 4 traces were picked up to plot in 
the lower panels. Fitting the GFP curve with an exponential decay function, we obtain 




Cells exhibiting Cdc14 endocycles did not show overt cell cycle progression as 
determined by budding, cytokinesis, or nuclear or nucleolar division.  The G1 cyclin 
CLN2 is expressed at cell cycle Start, as part of a large regulon (Wittenberg et al., 
1990).  To examine whether some aspects of cell cycle progression were proceeding 
despite the absence of morphological events, I examined CLN2 promoter activity 
using a CLN2pr-GFP-PEST construct (Bean et al., 2006; Mateus and Avery, 2000) as 
a molecular marker for cell-cycle progression in Clb2kd-blocked cells. I observed no 
significant CLN2pr expression while cells were undergoing Cdc14 endocycles, while 
a burst of CLN2pr expression occurred when these cells finally budded (Fig. 4.1E).  
This result also implies that the Cdc14 endocycle is not driven by oscillations in G1 







Figure 4.3.  Clb2kd-GFP activity leads to graded delay in rebudding. 
GAL1-CLB2kd-GFP strain was treated as in Fig. 4.1D. The rebudding time was 
plotted against Clb2kd-GFP concentration for each cell. Red line shows a fitting with 
a linear function (r=0.8, p=8x10-4).  The average rebudding time for unpulsed cells 









Figure 4.4.  Height and width of Cdc14 release peak are not affected by 
Clb2kd-GFP concentration up to 3-fold wild-type peak level.  Cells were treated 
as in Fig. 4.1D. In cases of Cdc14 endocycles, the height and width of the release 
peak is plotted against Clb2kd-GFP concentration. Cdc14 release in wildtype cells 






Figure 4.5.  Comparison of Clb2(kd) levels under various conditions.  Asy: 
asynchronous culture; GAL-CLB2kd: asynchronous culture of GAL-CLB2kd strain 
growing in raffinose. Galactose is added at time zero.  MET-CDC20: MET-CDC20 
strain in R+MET; CLB2kd:CLB2kd strain is first synchronized with alpha factor in 
galactose medium, and is released into either glucose or galactose (t=0). Numbers 
under lanes: Clb2/Pgk1 value, normalized by the value for asynchronous culture. 
Numbers in bracket: Adjusted Clb2/Pgk1 value. Anti-Clb2 antibody recognizes Clb2 
and Clb2kd with different affinity. We calibrate the Clb2 antibody using Clb2-YFP 
and Clb2kd-YFP, obtaining the correction factor ~2.0 (Clb2/Clb2kd). 
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In yeast, the MCM replicative helicase complex is excluded from the nucleus 
throughout the cell cycle except for late M and G1, and this regulation contributes to 
preventing pre-replicative complex formation except during these cell cycle stages 
(Kearsey and Cotterill, 2003).  Mcm2-GFP nuclear relocalization occurs sharply at 
ME.  ~1X peak Clb2kd-YFP was sufficient to completely block Mcm2-GFP nuclear 
accumulation before rebudding in the next G; lower levels of Clb2kd-YFP strongly 
but incompletely inhibited Mcm2 nuclear reentry (Fig. 4.6; Drapkin et al., in press).  
Consistent with this observation, I observed little or no DNA endoreduplication 
during Cdc14 endocycles by DNA flow cytometry (no accumulation of 4C peak, 
which would indicate an extra round of replication in undivided cells; Fig. 4.7).  
These observations confirm continuous high Clb2kd-associated kinase activity in vivo, 
and further confirm absence of molecular markers of cell cycle progression during 
Cdc14 endocycles. 
 
Despite constancy of Clb2kd levels and activity through this protocol (see above, 
and Drapkin et al., in press), I needed to determine whether endogenous mitotic 
cyclins might be oscillating and potentially controlling Cdc14 localization in cells 
exhibiting Cdc14 endocycles.  I tagged endogenous Clb2 with GFP in 
GAL1pr-CLB2kd cells, and found that Clb2-GFP was uniformly degraded after the 
initial Cdc14 release regardless of Clb2kd levels.  Clb2-GFP signal remained at the 
basal level through the period of Cdc14 endocycles, only reaccumulating upon exit 
from the endocycling state and re-entry into the next cell cycle (Fig. 4.8).  Thus, the 
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Cdc14 endocycle is most likely not driven by endogenous mitotic cyclin oscillations.  
 
Cdc14 endocycles are not driven by oscillations of stoichiometric inhibitors of 
Cdk, such as Sic1 (Verma et al., 1997), because pulsed Clb2kd was associated with 
constant histone H1 kinase activity, and Sic1 levels stayed low, and insufficient for 
Clb2kd inhibition, during the protocol (Drapkin et al. in press).  Consistently, Cdc14 
endocycles were independent of Swi5, the major SIC1 transcription factor (Toyn et al., 
1997)(Fig. 4.9).   
 
Overall, I conclude that Cdc14 release endocycles were not driven by oscillations 
of Clb2kd or Clb2-Cdk activity, and was likely independent of endogenous G1 or 
mitotic cyclins.  Cdc14 endocycles were observed in cells that failed to undergo cell 
cycle progression, as indicated by failure of cytokinesis, rebudding, Mcm complex 






Figure 4.6.  The response of Mcm2 nuclear localization to Clb2kd.  MCM2-GFP 
cells was pulsed with GAL1-CLB2kd-YFP for 30 minutes as in Fig. 4.1D, and released 
into cell cycle progression.  Coefficient of Variation(CV) of Mcm2-GFP in a single 
cell was used as a proxy for Mcm2 nuclear localization. An increase of CV indicates 
an increase of Mcm2-GFP nuclear concentration. Top four traces show 
CV(Mcm2-GFP) during the time course under various Clb2kd-YFP concentrations in 
the ‘peak’ unit (Materials and Methods). Bottom panel shows the height of 
CV(Mcm2-GFP) peak before budding vs. Clb2kd-YFP levels for both unpulsed 
control and pulsed cells. Note: due to cellular background fluctuations, the apparent 






Figure 4.7.  MET-CDC20 CDC15/cdc15-2 cells were pulsed with GAL1-Clb2kd for 
35 minutes at 28° permissive temperature before released from cdc20- block. After 
incubated at 28° for 40 minutes to allow anaphase and initial Cdc14 release, cultures 
were shifted to 37° restrictive temperature (t=0). FACS samples showing DNA 






Figure 4.8.  Endogenous Clb2 was degraded regardless of Clb2kd, and did not 
accumulate during Cdc14-release endocycles.  GAL1-CLB2kd was pulsed for 35 
minutes in cells whose endogenous Clb2 was tagged with GFP. Cdc14 release curve 
(blue) and GFP signal (green) were shown for 4 examples.  In the case of Cdc14 
release endocycles (lower two panels), Clb2-GFP signal remained low during the 
oscillation period (n=36). Vertical blue bar: nucleolar separation (anaphase); Vertical 





Figure 4.9.  Cdc14 endocycle is not disrupted by SWI5 deletion. 
GAL1-CLB2kd-GFP was pulsed for 30 minutes in swi5∆ cells before observation.  
representative samples show that Cdc14 endocycles persisted in swi5∆ cells(n=66). 
The number on each panel is Clb2kd-GFP concentration in the ‘peak’ unit (Materials 





3. Clb2kd levels quantitatively control the frequency of the 
Cdc14 release endocycle 
 
Cdc14 release cycles exhibited an interesting dose-response to Clb2kd.  In cells 
with a relatively low level of Clb2kd-GFP (less than ~0.5X peak), cell-cycle 
progression was not greatly disturbed, and a single cycle of Cdc14 release and 
resequestration followed anaphase (marked by nucleolar Net1 separation), as in 
normal cell cycles (Fig. 4.10A, category 1).  Cdc14 release in the next cell cycle of 
‘category 1’ cells was frequently delayed, possibly due to 2nd-cycle defects caused by 
low Clb2kd (Drapkin et al. in press).  At intermediate levels of Clb2kd-GFP (around 
0.75X peak), cytological ME was delayed but not blocked by Clb2kd, as reported 
(Drapkin et al., in press).  In some of these cells, a 2nd Cdc14-release event occurred 
rapidly after bud emergence, without an associated anaphase (Fig. 4.10A, category 2).  
At >=1X peak Clb2kd concentrations, the 2nd (and frequently additional) Cdc14 
release/resequestration cycles happened without cytokinesis, rebudding, CLN2pr 
expression or any other markers of cell cycle progression; these category 3 cells 








Figure 4.10.  Clb2kd level controls the Cdc14 endocycle period.  A. Trajectories 
for Clb2kd-pulsed cells. Category 1: essentially normal cell-cycle progression (though 
with 2nd cycle Clb2kd-induced delays; Drapkin et al., submitted); Category 2: a 
second Cdc14 release occurred between rebudding and nucleolar separation in the 
next cell cycle; Category 3: Cdc14 endocycles without cytokinesis or rebudding. 
Below: category means and standard deviations of Clb2kd-GFP concentration (blue) 
and Cdc14 release intervals (red) .  B. Cdc14 release frequencies plotted against 
Clb2kd-GFP level for cell categories: inverse of intervals between first and second 
Cdc14 release (categories 1 and 2), or average frequencies of one cell’s Cdc14 
endocycles (category 3).  Shaded: range of cell cycle frequencies for cycling 











It is interesting to note that category 2 cells represent an intermediate phenotype 
between normal tight linkage of Cdc14 release to cell cycle progression, and complete 
uncoupling as in category 3 endocycling cells.  Therefore, there is likely a 
continuous transition from normal Cdc14 release cycles to endocycle phenotypes with 
increasing Clb2kd concentrations. 
 
By plotting the frequencies of Cdc14-release oscillation versus the concentration 
of Clb2kd-GFP, I observed a positive correlation below ~1.7x peak Clb2kd 
concentration (P<2*10-7, using only data from cells that undergo endocycles without 
apparent cell cycle progression; ‘category 3’ in Fig. 4.10.  A quantitatively similar 
and highly significant positive correlation was observed using all three categories of 
cells).  This continuous response across the different phenotypic categories suggests 
that frequency of Cdc14 release may be directly controlled by Clb2 levels, 
independent of occurrence of some events of cell cycle progression.  At higher 
Clb2kd, the endocycle frequency saturated at about once every 45 minutes (Fig. 
4.10B).  For simplicity, I fitted this correlation with a linear step function.  This 
correlation is highly significant, and the slope determined with rather narrow 
confidence intervals (Fig. 4.10B legend).  There is obviously very considerable noise 
about this linear fit, which could be due to the intrinsic heterogeneity in the cell 
population.  In what follows, I will make use solely of the average dose-response 
relationship. 
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Although the frequencies of Cdc14 release cycles were positively controlled by 
Clb2kd, the amplitude and duration of Cdc14 release (whenever it occurred) did not 
significantly correlate with Clb2kd-GFP concentration (Fig. 4.4).   
 
These quantitative observations are important for my theoretical analysis below. 
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4. Requirement for Cdc14 release endocycle 
 
A free-running oscillator may drive G1 events in the absence all B-type cyclins 
(Haase and Reed, 1999; Orlando et al., 2008).  It was important to determine if this 
oscillator might also drive Cdc14 endocycles.  To test this, I overexpressed a stable 
Clb-Cdk inhibitor Sic1-4A from a GAL1 promoter to inhibit all B-type cyclin-Cdk 
activity (Verma et al., 1997).  Multiple budding without cell division (manifesting 
the free-running G1 oscillator, as described (Haase and Reed, 1999)) was observed 
following Clb inhibition.  However, I did not detect any Cdc14-release events in a 6 
hour time-course in these cells (Fig. 4.11) (this result, when compared to the Clb2kd 
results, also has the interesting implication that Cdc14 release endocycles may have a 
minimum ‘permissive’ level of mitotic cyclin activity required for their occurrence).  
Conversely, to test if Cdc14 was an essential component for the G1 oscillator, I 
constructed a strain harboring a temperature-sensitive mutant of cdc14-1 with all 
B-cyclin deleted.  I counted the multiple-budding phenotype in a time-course 
experiment from small G1 cells by elutriation, and found that cdc14-1 cells formed a 
second bud as efficiently as wild-type cells (Fig. 4.12).  Therefore, I conclude that 
the Cdc14 release and G1 endocycles are driven by distinct and independent 
mechanisms. 
 
The mitotic exit network (MEN) is a major regulator of Cdc14 release during late 
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anaphase (Stegmeier and Amon, 2004).  Cdc14 endocycles required the MEN 
component Cdc15, even after allowing an initial round of Cdc14 release (showing that 
the MEN is required for maintenance as well as initiation of endocycling) (Fig. 
4.13D).  The FEAR network is involved in a transient wave of early anaphase Cdc14 
release (Stegmeier et al., 2002); Cdc14 endocycles did not require the FEAR network 
component Spo12, or Net1 phosphorylation by Clb-Cdk, a key event in FEAR 
pathway activation (Azzam et al., 2004; Queralt et al., 2006) (Fig. 4.14).  In bub2Δ 
cells, MEN activity is likely to be near-constitutive (Alexandru et al., 1999; Pereira et 
al., 2000; Xu et al., 2000).  The Cdc14 release endocycles persisted in bub2Δ cells in 
the presence of Clb2kd (Fig. 4.14), suggesting that the Cdc14 endocycle may not be 







Figure 4.11.  Cdc14 release did not happen in Sic1-4A expressing cells.  
GAL1-SIC1-4A cells were grown in raffinose medium, then transfered to galactose 
medium to make time-lapse movies (t=0). No Cdc14 release was detected during the 








Figure 4.12.  The budding endocycle in clb1~6∆ cells was independent of  
Cdc14.  clb1~6∆ GAL1-CLB2 swe1∆ with CDC14 or cdc14-1 was grown in 
galactose medium at 23˚. Small G1 cells were collected through elutriation, and 
released into glucose medium at 37˚. Cells were harvested and counted for 
multi-budding phenotype at indicated time points. 
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Figure 4.13.  Requirements for Cdc14 endocycles.  A. As in Fig. 4.1B, but cells 
also cdc5::3XCDC5ΔNT . Among cells whose rebudding was delayed for at least 25 
minutes (implying >1X peak Clb2kd, Fig. 4.3), 19/36 cells showed fast Cdc14 release 
and resequestration, followed by prolonged Cdc14 release. 8/36 showed only 
prolonged Cdc14 release.  B. As in Fig. 4.1D, but also cdh1Δ; 30 min Clb2kd-GFP 
pulse; typical traces for the indicated Clb2kd-GFP ranges.  Among cells with >1X 
peak Clb2kd-GFP (n=86), 41% showed a prolonged Cdc14 release period (middle 
two traces); 43% (cells with highest Clb2kd-GFP) showed release endocycles with a 
reduced amplitude (bottom trace); Blue bars: anaphase; Red bars: cytokinesis; green 
bars: bud emergence.  C. CDC5pr-GFP cells, as in Fig. 4.1B.  Trough GFP 
intensities before rebudding plotted against rebudding times; rebudding delay 
indicates Clb2kd levels; sample traces below.  D. Cells as in Fig. 4.1D, but also 
cdc15-2 or cdc5-1; after 35 min to allow initial Cdc14 release, cells were plated for 
time-lapse at 37oC (restrictive temperature) (t=0).  CHX: as above, except that 
time-lapse medium contained 0.2ng/μl cycloheximide (CHX). Among cells with >1X 
peak Clb2kd-GFP, 18/24 CDC15 CDC5 cells, 0/22 cdc15-2, 0/30 cdc5-1 and 3/64 
cells in CHX exhibited Cdc14 release endocycles..  Blue bars: anaphase; green bars: 
bud emergence.  E: As in Fig. 4.1B, but CDC5-GFP cells; 30 min Clb2kd pulsed; 
typical traces of Cdc14 release and Cdc5-GFP levels are shown.  In 36/45 
Cdc14-endocycling cells, Cdc5-GFP signal oscillated in-phase with Cdc14 release.  
F. ODE model simulating Cdc14-Cdh1-Cdc5 negative feedback (Materials and 







Polo kinase Cdc5 is essential for Cdc14 release, in both the FEAR and MEN 
pathways, and Cdc5 overexpression can drive ectopic Cdc14 release in 
S-phase-blocked cells (Visintin et al., 2003).  Using a cdc5-1 temperature-sensitive 
mutation, I determined that Cdc5 activity was absolutely required for maintenance of 
Cdc14 endocycles (Fig. 4.13D). 
 
Thus, Cdc14 endocycles in Clb2kd-blocked cells share requirements with normal 
late-anaphase Cdc14 release, supporting the idea that the endocycles may involve 
mechanisms controlling Cdc14 release in the free-running cell cycle. 
 
Cdc14 endocycles in Clb2kd-blocked cells require resequestration into the 
nucleolus after each release.  Cdc5 is essential for normal Cdc14 release, and Cdc5 is 
down-regulated at the end of mitosis by inactivation of its transcription and by 
Cdh1-APC-dependent proteolysis (Charles et al., 1998; Shirayama et al., 1998); Cdc5 
proteolysis contributes to Cdc14 resequestration into the nucleolus (Visintin et al., 
2008).  Therefore, to ask if resequestration in endocycles shared requirements with 
resequestration in the free-running cycle, I tested Cdh1-resistant Cdc5-ΔNT (using 3X 
CDC5-ΔNT, an allele that produces near-wild-type Cdc5 kinase levels, without 
proteolytic regulation of Cdc5 protein abundance (Visintin et al., 2008)). 3X 
CDC5-ΔNT severely inhibited Cdc14 endocycles.  In 3X CDC5-ΔNT cells deduced 
to contain >1X peak Clb2kd, I did not detect multiple Cdc14 release endocycles.  
Instead, 22% of cells showed an extended Cdc14 release period, and 52% of cells had 
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a short Cdc14 release/re-sequestration cycle prior to a long release period (Fig. 4.13A).  
As noted above, the release period in Cdc14 endocycles in CDC5+ cells are of normal 
duration and amplitude, unlike the very long release periods in 3X CDC5-ΔNT cells. 
 
CDH1 is required for cell-cycle-regulated Cdc5 degradation.  Consistent with 
results with CDC5-ΔNT, cdh1Δ but not CDH1 cells containing 0.5X to 2X peak 
Clb2kd released Cdc14 for up to 80 minutes, and did not exhibit Cdc14 endocycles 
(Fig. 4.13B).  Surprisingly, however, I observed Cdc14 endocycles in cdh1Δ cells 
with > 2X peak Clb2kd, but release was incomplete (about half the normal amplitude) 
(Fig. 4.13B).  This result indicates the existence of a parallel Cdh1-independent 
pathway allowing Cdc14 endocycles; but the primary mechanism likely requires 








Figure 4.14.  Cdc14 endocycles occured in spo12∆, net1-6Cdk, bub2∆ cells.   All 
three strains contain MET-CDC20 CDC14-YFP NET1-mCherry MYO1-GFP 
GAL1-CLB2kd-GFP GAL4-rMR with additional genotypes indicated above.  
Cultures were pulsed with Clb2kd-GFP for 30 minutes, and subjected to time-lapse 
microscopy analysis as in Fig. 4.1D.  Unpulsed controls are shown in the top row.  
bub2∆ cdc15-2 cells were arrested and pulsed at 34°, and released at 27° (Using 
cdc15-2 is to achieve a stable arrest at cdc20-).  Among cells with >1X peak 
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5. A Cdc14-Cdh1-Cdc5 negative feedback mechanism 
contributes to Cdc14 endocycle 
 
Cdc14 endocycles are abrogated either by loss of Cdc5 (in cdc5-1 cells), or by 
blocking Cdc5 degradation, presumably increasing Cdc5 levels (in CDC5-ΔNT or 
cdh1Δ cells).  This could reflect a requirement for cyclical Cdc5 activity for Cdc14 
endocycles, since they are prevented by either constitutively high or constitutively 
low Cdc5. 
 
I hypothesized that mitotically active Cdc5 would promote Cdc14 release, Cdc14 
would activate Cdh1 leading to Cdc5 proteolysis, and Cdc14 would reaccumulate in 
the nucleolus.  In the wild-type cell cycle, Cdc5 cannot reaccumulate until the next 
M-phase: CDC5 is co-transcribed with CLB2 under Clb2-dependent positive feedback 
control (Wittenberg and Reed, 2005), so Clb2 removal at anaphase blocks further 
CDC5 transcription.  In addition, absence of Cdk activity in G1 keeps Cdh1 active 
until later cyclin-Cdk reactivation.  In Clb2kd-blocked cells, though, persistent 
Clb2kd could both maintain CDC5 transcription, and inactivate Cdh1, in the absence 
of counterbalancing dephosphorylation by Cdc14, allowing rapid reaccumulation of 
Cdc5 and endocyclic Cdc14 release and resequestration.  This negative feedback 
hypothesis would explain the absence of endocycles in cdc5-1, CDC5-ΔNT and cdh1Δ 
cells.   
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Consistent with this hypothesis, I observed higher trough levels and rapid rebound 
of CDC5 transcription in Clb2kd-pulsed cells compared to unpulsed controls (Fig. 
4.13C), using a cell-cycle-regulated CDC5pr-GFP reporter (J. Skotheim, pers. 
comm.).     
 
Also consistent with the hypothesis, Cdc14 endocycles required new protein 
synthesis, since endocycles were blocked by addition of cycloheximide after an initial 
Cdc14 release (Fig. 4.13D). Finally, in cells undergoing Cdc14 endocycles, I observed 
cyclical accumulation and degradation of Cdc5-GFP fusion protein expressed from 
the endogenous promoter, in approximately the expected phase relative to Cdc14 
release (Fig. 4.13F). 
  
A qualitative ODE model (Fig. 4.13E) of a Cdc5-Cdc14-Cdh1 negative feedback 
loop reproduced my major qualitative results, including dependence of Cdc14 








Figure 4.15.  Cdc14 endocycle frequency vs. Clb2kd level by ODE simulation.  
Clb2kd concentration was changed continuously as a parameter in the ODE model 
simulating Cdc5-Cdc14-Cdh1 negative feedback (Materials and Methods).  Cdc14 
release frequency was calculated from the simulation. 
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This negative feedback mechanism is probably the main but not the only source of 
Cdc14 endocycles.  Cdh1-dependent Cdc5 degradation cannot be strictly essential 
for resequestration, since resequestration was delayed but not blocked in CDC5-ΔNT 
and cdh1Δ cells, and I observed low-amplitude endocycles in cdh1Δ cells at very high 
(>2X peak) Clb2kd levels. 
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6. An intrinsic oscillatory module may control normal 
Cdc14 release in unperturbed cell cycles 
 
I used cell cycle block with undegradable Clb2 to demonstrate an oscillatory 
module controlling Cdc14 localization in the absence of cyclin-Cdk oscillations. 
 
The emergence of Cdc14 release endocycles at high (but physiological) Clb2kd 
levels could come about because Clb2kd accelerates the Cdc14-release-control 
module (Fig. 4.10B) and greatly delays Clb-Cdk oscillation, temporally separating 
these oscillators.  Mechanistically, acceleration of the Cdc14 module could derive 
from rapid rebound of the Cdc5-Cdc14-Cdh1 negative feedback oscillator with high 
locked Clb2 levels (see above); the stalling of the Clb-Cdk oscillation is a direct 
consequence of blocking Clb2 degradation. 
 
Cdc14 endocycle phenotypes are only of clear physiological importance only if 
this module and its self-oscillatory behavior are coupled to normal Cdc14 release in 
unperturbed cell cycles.  However, any experiments trying to reveal the module’s 
intrinsic behavior will inevitably perturb normal cell cycle progression.  Therefore, I 
try to answer this question in two steps: 1. whether the Cdc14-release module can 
oscillate autonomously in free-running cell cycles; 2. whether normal Cdc14 release 
cycles are also promoted by self-oscillatory behavior of this module.  To study the 
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first question, I looked for ways to uncouple the hypothetical Cdc14 oscillatory 
module from the Clb-Cdk oscillator, without blocking the cell cycle.  Genetic 
manipulations providing sufficient uncoupling could allow detection of Cdc14 release 
endocycles in a free-running cell cycle.  Plausible coupling components include: 1. 
CDC5 transcription, activated by Clb-Cdk; 2. Cdh1, activated by Cdc14 and 
degrading Clbs and Cdc5; 3. the MEN, indirectly activated by mitotic cyclin-Cdk, 
since anaphase (promoted by cyclin-Cdk (Fitch et al., 1992)) in turn activates the 
MEN (Fig. 4.16).   
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Figure 4.16.  Cdc14 release endocycles in free-running cell cycles or with low 
Clb2kd.   A. Cdc14 release and Clb-Cdk control mechanisms. Left: potential 
autonomous Cdc14 release oscillator; right: Clb-Cdk negative-feedback oscillator.  
SPOC: spindle orientation checkpoint.  B. Cdc14 release analyzed as in Fig. 4.1D, in 
bub2Δ cdh1Δ and GAL1-URL-CDC5 cells (cycling cells, without cdc20 block-release 
or Clb2kd pulse).  A representative lineage (M0: mother, D1, D2...sequential 
daughters) exhibiting ectopic Cdc14 release (red) before bud emergence.  Cdc14 
release curves shifted for visualization.  Below: frequencies of G1 Cdc14 endocycles.  
C. 67μM Latrunculin-B (LAT-B) was added to the medium (t=0) to inhibit budding of 
a cycling bub2Δ cdh1Δ strain.  32/44 cells demonstrated G1 Cdc14 endocycles.  
14/19 daughter cells and 13/19 mother cells exhibited endocycles (maximum 4 
endocycles; average=2.8).  D. MET-CDC20 bub2Δ cdc15-2 cells were arrested in 
metaphase at 34℃ and pulsed with Clb2kd-GFP for 20 minutes (using cdc15-2 is to 
achieve a stable cdc20- block), then released into cell cycle at 27℃ with 67μM 
LAT-B to observe. The first anaphase (nucleolar separation) happened with normal 
kinetics. LAT-B effectively blocked budding, cytokinesis, and all subsequent anaphase 
in ~90% cells. 39/46 cells containing 0.2~1.0x peak Clb2kd-GFP demonstrated Cdc14 
endocycles. Four traces are shown. The ‘Cdc14 endocycle frequency vs. Clb2kd-GFP 
levels’ information is plotted together with the data in Fig. 4.10B. Blue bars: anaphase; 






Following this reasoning, I tested the effects of making CDC5 transcription 
independent of Clb-Cdk, using a GAL1-URL-CDC5 construct (Visintin et al., 2008); 
the destabilizing URL tag was required to keep Cdc5 at a non-lethal level).  
GAL1-URL-CDC5 cells are fully viable in galactose medium.  Consistent with the 
oscillatory module hypothesis, I observed a G1-specific Cdc14 release endocycle in 
~70% of daughter cells (Fig. 4.16B).  The observation of Cdc14 endocycles in G1 is 
completely unexpected on the basis of any model involving ratchet-type control by 
cyclin-Cdk.  (G1 cells stably contain almost no cyclin-Cdk activity (Mendenhall and 
Hodge, 1998), so any event controlled by a cyclin-Cdk ratchet event has no basis for 
repeated activity in G1 cells).  
 
Deletion of CDH1 could also be predicted to weaken the coupling.  However, I 
did not observe Cdc14 endocycles or Cdc14 release anomalies in cycling cdh1Δ cells.  
One explanation for this could be that Cdh1 plays an important role not only in 
coupling, but in the Cdc14 intrinsic oscillatory mechanism itself (see above; Fig. 
4.13B).  My data suggest, though, that Cdh1 is not absolutely essential for Cdc14 
cycles, since Cdc14 resequestration is eventually observed in Clb2kd-pulsed cdh1Δ 
cells, and at high Clb2kd levels, low amplitude Cdc14 endocycles re-emerge.  If this 
idea is correct, more complete decoupling could reveal Cdc14 release endocycles in 
the absence of Cdh1, if they can be driven by parallel coupled pathway(s).  I further 
reduced the coupling by deleting BUB2, removing an MEN inhibitor that keeps MEN 
activation dependent on anaphase (Fesquet et al., 1999; Pereira et al., 2000), and thus, 
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indirectly, dependence on mitotic cyclins that are required for anaphase (Fitch et al., 
1992).  Similar to GAL1-URL-CDC5 cells, I observed G1-specific Cdc14 release 
endocycles in cycling cdh1Δ bub2Δ cells (again only in daughter cells and with 
incomplete penetrance) (Fig. 4.16B).  BUB2 deletion slightly increased the 
penetrance of Cdc14 endocycle phenotypes in GAL1-URL-CDC5 cells (Fig. 4.16B; 
4.17), but did not alone induce endocycles (data not shown).  CDC5-ΔNT in a CDH1 








Figure 4.17.  Cdc14 endocycles in G1 bub2∆ cdc5::GAL1-URL-CDC5 cells.  
Asynchronous bub2∆ cdc5::GAL1-URL-CDC5 cells were grown in galactose medium 
and subjected to time-lapse microscopy analysis. Two examples here show Cdc14 
release endocycles in G1 daughter cells.  Traces are shifted along Y-axis for 
presentation. In the whole population, 61% daughter cells show the endocycle 
phenotype(n=18). Only 9% mother cells show this phenotype(n=22). The mother cell 
M0 gave rise to the first daughter cell D1, and the second daughter cell D2. Blue bar: 





Figure 4.18.  Cdc14 endocycles in G1 cdc5::3xCDC5∆NT cells. Log phase 
cdc5::3xCDC5∆NT culture was subjected to time-lapse microscopy analysis. An 
example shows Cdc14 release endocycles in a G1 daughter cell (D2). The mother cell 
M0 gave rise to the first daughter cell D1, then the second daughter cell D2. In the 
whole population, 23% daughter cells showed the endocycle phenotype in G1 (red; 
n=21); Only 3% mother cells showed this phenotype (n=30). Traces were shifted 
along Y-axis for presentation. Blue bars: anaphase; green bars: budding. 
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The daughter-preference of the endocycle phenotype could be due to 
G1-cyclin-dependent relocalization of MEN activators such as Lte1 to the incipient 
bud (Jensen et al., 2002), thus sequestering these activators until spindle pole entry 
into the bud in the next cell cycle.  Mothers bud and express G1 cyclins much earlier 
than daughters (Di Talia et al., 2007), which could forestall any G1 Cdc14 endocycles, 
explaining the observed daughter preference of endocycles.  Actin depolymerization 
with latrunculin B prevents budding; G1-cyclin-dependent Lte1 relocalization to the 
cortex still occurs but cortex-bound Lte1 cannot be sequestered in a bud (Jensen et al., 
2002).  Addition of latrunculin B to cdh1Δ bub2Δ cells allowed Cdc14 endocycles in 
G1 mothers as well as G1 daughters with equal probability (Fig. 4.16C).  I observed 
up to four cycles of Cdc14 release and resequestration in these cells, in most cases 
without associated anaphase.   
 
These results establish that the genetic network controlling Cdc14 localization has 
the intrinsic ability to oscillate even in free-running cell cycles.  This demonstration 
required some alteration of normal control circuits, leaving the question open as to 
whether the Cdc14-release control module still exhibits self-oscillatory behavior when 
promoting normal Cdc14 release cycles in wild-type cells.  There are some 
suggestions in the data so far presented that this could be the case.  First, ’category 2’ 
cells described above form an intermediate phenotype in a continuous transition from 
normal Cdc14 release cycles to the endocycle phenotype (Fig. 4.10A and text).  The 
simplest explanation is that normal Cdc14 cycles and endocycles are driven by the 
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same network whose kinetic parameters are tuned by mitotic cyclin activity.  Second, 
my estimate of the frequency of Cdc14 release oscillation at approximately mid-cell 
cycle Clb2 levels, by extrapolation, is ~95 minutes, i.e., close to the normal cell cycle 
frequency (Fig. 4.10B).  Third, genetic requirements for Cdc14 endocycles and for 
normal Cdc14 release are similar.  Both required Cdc5 and Cdc15, and shared a 
requirement for Cdh1-dependent degradation of Cdc5 for efficient Cdc14 
resequestration.  Fourth, the complete absence of Cdc14 endocycles at zero Clb-Cdk 
activity and the appearance of endocycles at ~1X peak Clb2kd (Fig. 4.11; 4.1), 
suggests that the Cdc14-release-control module undergoes a ‘Hopf’ bifurcation to 
give rise to limit cycle behaviors at a specific Clb2-Cdk level less than the peak.  
Direct measurement of the critical Clb2-Cdk level is difficult currently since Cdc14 
release oscillation is coupled with cell cycle progression and endogenous Clb2 
expression at sub-peak Clb2kd levels.  However, ‘Hopf’ bifurcation is known to 
have a generic (independent of functional forms or parameters) property that the 
oscillation amplitude scales as ~ )22( CriticalkdClbkdClb −  around the bifurcation point.  
In my experiments, Cdc14 endocycle always oscillates with full amplitude around 1X 
peak Clb2kd (Fig. 4.1; 4.4), suggesting that the critical Clb2kd level at bifurcation 
point should be significantly lower that 1x peak, which supports the idea that the 
Cdc14 control system also operates at an oscillatory zone in wild type cells. 
 
 To explore this question further, I study if the intact Cdc14-release module can 
still generate Cdc14 release cycles of a cell-cycle period under low Clb2 conditions 
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(comparable to average Clb2 in a cell cycle).  With <1X peak Clb2kd, I used LAT-B 
to inhibit cytokinesis, budding and anaphase to study the autonomous behavior of this 
module.  I also deleted BUB2 to avoid the interference of SPOC.  In the absence of 
cell cycle progression by LAT-B, Cdc14 release cycles of a 90-minute period emerged 
at 0.2X peak Clb2kd-GFP (Fig. 4.16D).  With <1X peak Clb2kd, 39/46 cells 
exhibited Cdc14 endocycles, and the frequency-Clb2kd relationship followed a 
similar rule as in Fig. 4.10B (Fig. 4.16E).  This result suggests that when promoting 
normal Cdc14 release, this module still exhibits self-oscillatory behavior, though 
entrained to cell cycle progression.  Overall, those experiments suggest that this 
module and its oscillatory behavior may control normal Cdc14 release in unperturbed 
cell cycles, and the coupling of this module with cyclin-Cdk oscillator is required for 
maintaining once-per-cell-cycle Cdc14 release in mitosis. 
 
Control of Cdc14 release by an autonomous oscillator must be compatible with 
the well-established restriction of Cdc14 release to late mitosis, at the end of the 
cyclin-Cdk cycle.  In the following sections, I propose that the Cdc14 oscillator is 
entrained by the cyclin-Cdk oscillator, and extend this concept to other likely 
oscillatory modules controlling different cell cycle events. 
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7. Cyclin-Cdk oscillations could order cell cycle events 
through phase-locking 
 
Besides the Cdc14 endocycle, other key cell cycle events can occur 
‘endocyclically’ in the absence of mitotic cyclin-Cdk oscillation or overall cell cycle 
progression (see Introduction), and thus have the capacity to be driven by intrinsic 
oscillating modules.  These observations are difficult to fit into the Cdk-ratchet 
model, since two essential components of the ratchet model, Cdk activity oscillation 
as the sole driver for cell cycle periodicity, and specific distinct Cdk thresholds for 
multiple steps in each process, are irrelevant in such situations.  Therefore, I 
considered other ways that cyclin-Cdk oscillations could still order cell cycle events, 
independent of ratchet-like mechanisms. 
 
My observation that the frequency of Cdc14 release endocycle was controlled by 
Clb2kd concentration (Fig. 4.10B) within a physiological range suggests that 
cyclin-Cdk oscillations could entrain other autonomous oscillatory modules to form 
an orderly and coherent cell cycle progression (Fig. 4.19A).  Such entrainment, or 
‘phase-locking’, is a known phenomenon in which oscillators with difference intrinsic 
frequencies can synchronize, if the frequency of one is controlled by the activity of 
the other (Glass, 2001; Winfree, 1967).  When phase-locked, their stable phase offset 
is determined by their intrinsic frequency difference and simple properties of their 
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Figure 4.19.  Cell cycle control through phase-locking.  A. Schematic of ratchet 
(above) and phase-locking (below).  B.  Conceptual model: three Kuramoto 
oscillators ((Kuramoto, 1975), Materials and Methods) with different frequencies 
(indicated) control different cell cycle events.  Without entrainment there is no fixed 
order (left) among events they generate. Allowing a cyclin-Cdk oscillator to advance 
or delay part of the peripheral oscillators’ cycles leads to phase-locking and a stable 
order of events (Right). 
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To demonstrate how phase-locking could order cell cycle events controlled by 
independent modular oscillators, I built a conceptual model containing four oscillating 
modules.  One is the cyclin-Cdk oscillator, and the other three are autonomous 
‘peripheral’ oscillators controlling specific cell cycle events (in this example, loosely 
modeled after budding, SPB duplication, [see Introduction] and Cdc14 release).  
Without any coupling, the different intrinsic frequencies of the peripheral oscillators 
results in a disordered and irregular relative sequence of cell cycle events (Fig. 4.19B, 
left).  Computer simulations showed that allowing the cyclin-Cdk master oscillator 
to affect the frequencies of the peripheral oscillators resulted in the three peripheral 
modules oscillating at a common frequency, producing events occurring once per 
cyclin-Cdk cycle in a fixed order (Fig. 4.19B, right).   
 
The model in Fig. 4.19B is only a cartoon representation of a possible cell cycle 
control mechanism.  However, the qualitative result of a distinct, dynamically stable 
phase-locking solution for each oscillating module, given sufficient interactions with 
the Cdk oscillator, may be robust to true biological complexity, since the stability of 
the phase-locking solution is only determined by the local dynamical structure near 
the fixed point (Winfree, 1967), meaning that phase-locking can occur largely 
independent of detailed mechanism.  The only requirements are sufficiently strong 
linkage, combined with reasonably close intrinsic frequencies; both of these features 
are likely highly evolvable given initially independent oscillators (see Discussion). 
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8. Reducing amplitude of the cyclin-Cdk oscillator results in 
disordered cell cycle events 
 
Phase-locking models of the general sort shown in Fig. 4.19B lead to a key 
prediction: lowering the amplitude of Clb-Cdk oscillation should simultaneously 
weaken entrainment between the Clb cycle and other Clb-controlled events, 
potentially perturbing the order of cell-cycle events (Fig. 4.20A).  Thus, if other cell 
cycle events are under control of other independent oscillators, then reducing the 
amplitude of Clb-Cdk oscillations could result in scrambling of the order of these 
events.  
 
Importantly, this prediction is largely independent of the detailed structure or 
parameters of the phase-locking model.  An entirely different prediction is made 
based on ratchet-type control (again, largely independent of detailed mechanism): 






Figure 4.20.  Experimental test of phase-locking predictions.  A. Model as in Fig. 
4.19B, but the amplitude of cyclin-Cdk oscillation is reduced by 15%, resulting in 
event disorder (compare Fig. 4.19B, right).  B. 2XGAL1-SIC1 bub2Δ or cdh1Δ sic1Δ 
bub2Δ strains may reduce the amplitude of cyclin-Cdk oscillation by lowering the 
peak Cdk activity or raising the trough (cartoon below).  2XGAL1-SIC1 cells (n=37) 
were grown in raffinose medium prior to time-lapse analysis on galactose medium to 
induce Sic1 (t=0).  cdh1Δ sic1Δ GALL-CDC20 cells (n=35) were imaged on glucose 
to turn off GALL-CDC20.  Quantification of the phenotype of the first cell cycle 
(right) and representative traces.  Blue bars: nucleolar separation; Green bars: 
budding; red bars: cytokinesis.  C. Cdc14 release and SPB duplication timing in 
free-running cell cycles predicted by a quantitative phase-locking model. Red: best 
estimation of parameters; blue: sine wave simulation of Clb-Cdk cycle. Light-red: 
solutions with parameters altered +/- one standard deviation for one or both of the two 
parameters (for two combinations no solution could be obtained due to mathematical 
restrictions of the model; Materials and Methods). Right panel: phase-locking could 
entrain SPB duplication oscillator (red) to the correct position early in the Clb-Cdk 







I tried two strategies to test this prediction, that lowering the amplitude of 
cyclin-Cdk oscillation should perturb the order of cell cycle events.  I first used 
strong constitutive overexpression of the Sic1 inhibitor of Clb-Cdk activity from the 
GAL1 promoter (Mendenhall and Hodge, 1998).  Wild-type cells already have a very 
low trough (G1) level of Clb-Cdk activity due to high endogenous Sic1 accumulation 
and other mechanisms (Mendenhall and Hodge, 1998) ; Sic1 overexpression therefore 
seems unlikely to lower the trough level further, but could lower the peak level by 
constitutive inhibitor production, thus reducing the amplitude (Fig. 4.20B). 
2XGAL1-SIC1 cells are fully viable on galactose medium, so this perturbation is, on 
the surface, not an extreme one.  As a nearly opposite means to lower the amplitude, 
I used deletion of CDH1 and SIC1, which results in a high trough level of Clb2-Cdk 
activity, probably not much lower than the peak level (Schwab et al., 1997; Visintin et 
al., 1997) (Fig. 4.20B).  Although cdh1Δ sic1Δ cells are ultimately inviable (Schwab 
et al., 1997; Visintin et al., 1997), they undergo multiple cell cycles (Wäsch and Cross, 
2002), allowing analysis of order of events by time-lapse microscopy.  Note that 
these two mechanisms for reducing the amplitude may do so in one case by lowering 
the peak, and in the other case by raising the trough.  A ratchet control model, in 
which specific Clb-Cdk levels are controlling sequential steps in a process, should 
predict very different results from these manipulations, since Clb-Cdk activity levels 
will be very different; for example, in GAL-SIC1 cells, Clb-Cdk levels are extremely 
low during an extended G1, while in cdh1Δ sic1Δ cells there is probably no period 
with low Clb-Cdk levels (Wäsch and Cross, 2002).  In contrast, the phase-locking 
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perspective can predict qualitatively similar outcomes of event disorder, and even 
obtaining identical outcomes is theoretically possible, depending on the nature and 
strength of coupling.  
 
In these experiments, in order to focus specifically on reduction of amplitude of 
the Clb-Cdk oscillation, I also knocked out the spindle orientation checkpoint 
component BUB2, which should relieve dependence of Cdc14 release on spindle 
positioning (Bardin et al., 2000).  (This genetic manipulation was indeed necessary 
for the full effects described below, although qualitatively similar effects on budding, 
cytokinesis, and anaphase were observed in a BUB2 background; bub2 deletion alone 
had no effect [data not shown]).  
 
GAL1-SIC1 expression in bub2Δ cells resulted in 64% abnormal first cell cycles 
after Sic1 expression on galactose medium (supernumerary Cdc14 release without 
nucleolar separation; extra budding without Cdc14 release or cell division; or 
cytokinesis without Cdc14 release or nucleolar separation (Fig. 4.20B), resulting in a 
supernumerary bud following cytokinesis, which then fails to grow, presumably due 
to being anucleate).  Remarkably, similar cell cycle anomalies with roughly similar 
frequencies were also observed in cycling cdh1Δ sic1Δ bub2Δ cells.   
 
The conceptual phase-locking model qualitatively reproduced the loss-of-order 
phenotypes resulting from lowering the amplitude of Cdk oscillation (Fig. 4.20A).  
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Those anomalies are not likely due to nonspecific growth defects since GAL1-SIC1 
bub2 cells grow well both in bulk culture and when monitored as single cells.  cdh1Δ 
sic1Δ occasionally causes permanent cell cycle block with large budded cells; such 
cells were excluded from analysis.  In contrast, any Cdk-ratchet model would predict 
that reducing the Cdk oscillation amplitude will lead to elongation of cell cycle period 
or complete block of cell cycle progression; in either case, the normal orders of cell 
cycle events would be predicted to remain the same.  Further, near-opposite 
phenotypes would be predicted for lowering the peak vs. raising the trough.  
Therefore, these results support phase-locking over ratchet control. 
 
The phase-locking model describes how Cdk oscillation entrains autonomous 
peripheral oscillators to form a coherent cell cycle.  This model coherently associates 
the cycling of an event (e.g. Cdc14 release, SPB duplication) in normal cell cycles 
with its capacity to operate in endocycles in blocked cells.  The phase-locking model 
implies that these two phenotypes are driven by the same inherently oscillatory 
module, which is entrained to the cyclin-Cdk oscillation in normally cycling cells.  
In contrast, these two phenotypes are essentially uncoupled and independent of each 
other in any ratchet model that somehow incorporates the possibility of endocycles as 
a (pathological) consequence of cell cycle blockage.  Therefore, an empirical test of 
the phase-locking vs. the ratchet perspective is to ask whether the response of the 
oscillatory module to fixed Clb-Cdk levels is predictive of timing in the normal cell 
cycle.  To carry out this test, I derived an equation to calculate the stable phase offset 
158
(the difference between peak Clb2 and peak Cdc14 release), based on the 
phase-locking model.  This model contained only three parameters, all of which 
were extracted directly from the empirical observations (importantly, derived solely 
from Clb2kd-blocked cells) in Fig. 4.10B (Materials and Methods).  A key parameter 
is the strength of coupling of Clb2 to the frequency of the Cdc14 cycles (as noted 
above, such coupling is indispensable for a phase-locking mechanism); this is simply 
determined as the slope of the straight-line fit in Fig. 4.10B.  I solved the model 
analytically to determine the phase-offset.  This calculation placed Cdc14 release 
late in the cell cycle, as Clb-Cdk levels decreased, consistent with experiment 
(Stegmeier and Amon, 2004).  This conclusion is not especially sensitive to 
uncertainties in estimating the parameters, since a similar result is obtained increasing 
or decreasing the parameter estimates by one standard deviation of measurement error, 
alone or in combination (Fig. 4.20C).  A ratchet model can accommodate the 
observations of Cdc14 endocycles in Clb2kd cells only by asserting that these 
endocycles are due to pathological conditions of Clb2kd accumulation; in this case, 
parameters derived from experiments with Clb2kd-blocked cells will be irrelevant to 
timing in cycling cells.  
 
The phase-locking model can be applied to any oscillating module under the 
control of Cdk activity.  I performed the same test on the hypothesized SPB 
duplication module to see if this model can ‘predict’ the timing of SPB duplication in 
normal cell cycles.  Published data are insufficient to obtain empirical estimates of 
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parameters to calculate the timing of SPB duplications.  Still, I could estimate 
predicted timing using my model and plausible parameter choices (Materials and 
Methods).  SPB duplication was predicted to occur early in the cell cycle, before the 
rise in Clb-Cdk, as observed experimentally (Fig. 4.20C).  This result shows 
consistency of timing of SPB duplication with a phase-locking model.  
 
The severe disruptions in normal Cdc14 release by manipulations specifically 
predicted to perturb the autonomous Cdc14 release module, even in free-running cell 
cycles, imply that oscillatory function of this module and its coupling to Clb-Cdk 
oscillations is required for normal Cdc14 release timing.  It is likely that any 
phase-locking control system could transit evolutionarily to a pure ratchet-control 
system; indeed, this is formally the result of increasing coupling strength to arbitrarily 
high values, such that the peripheral oscillator will not move within a physiological 
timescale without a ‘kick’ from the entraining oscillator.  Different cell cycle systems, 
even if initially independently oscillatory, may vary in the degree to which they are at 
present under ratchet control; for example, DNA replication may be entirely under 
cyclin-Cdk ratchet control in modern eukaryotes, despite its intrinsically oscillatory 
character.  This may represent a tradeoff between the robustness and simplicity of 
the PL mechanism, and the cost in some systems of occasional uncoupling 
(aneuploidy in the case of DNA replication).   
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9. Implications for the evolution of the cell cycle 
 
Modularity in biology has been argued to create functional robustness and 
evolvability (Bhattacharyya et al., 2006; Hartwell et al., 1999).  My study suggests 
that certain modules in cell cycle are intrinsically oscillatory; coupling of these 
oscillators to the central Cdk oscillator can nevertheless readily ensure 
once-per-cell-cycle events (Fig. 4.19A).  
 
The eukaryotic cell cycle evolved from Cdk-free precursor(s), since Cdk is a 
eukaryotic-specific kinase (Nasmyth, 1995).  Critical biological processes such as 
DNA replication and cell division obviously predated Cdk, and may be intrinsically 
cyclical processes ultimately brought under control of a Cdk oscillator by 
phase-locking.  Consistent with this idea, Cdks may have evolved late, after other 
eukaryotic cell-cycle-regulatory protein kinases (Krylov et al., 2003).  If cell cycle 
processes were intrinsically oscillatory before the emergence of Cdk, then Cdk would 
only need to gain the ability to modulate these oscillators to gradually become a 
master regulator.  This provides a clear evolutionary case with plausible selection for 
utility of intermediate forms (Darwin, 1859).  In contrast, direct evolution of ratchet 
control appears to require much more ‘forceful’ evolutionary change.   
 
I speculate that in primordial eukaryotes, multiple autonomous biochemical 
oscillators entrained each other to an approximate aggregate rhythm.  Cyclin-Cdk 
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oscillation could then have emerged as a central cell cycle controller to stabilize the 
phase-locking structure.  In computer simulations, selection for entrainment in large 
oscillator populations efficiently yielded central pacemaker oscillators (Brede, 2008; 
Sendina-Nadal et al., 2008).  These evolved pacemaker systems exhibited high 
stability to weakening of oscillator coupling as an unselected ‘phenotype’ (Brede, 
2008).  To understand the advantage of having a central oscillatory controller like 
Cdk, I constructed random networks of coupled Kuramoto oscillators (Kuramoto, 
1975) in computer simulation.  Increasing centralization of control by gradually 
changing network connections increased the stability of spontaneous entrainment (Fig. 





Figure 4.21.  Simulation showing that centralization of control enhances global 
entrainment in an oscillator network.  For a range of coupling strengths 
(equivalent to magnitude of the Z response curve; see Materials and Methods) on the 
x-axis, we randomly generated Kuramoto oscillator networks containing 100 
independent oscillators, either connected randomly (black), or with preference for 
in-connection from an oscillator that already has multiple out-connections 
(preferential exponent=1.0 in green, or 2.0 in blue, see Materials and Methods). For 
all networks, the average number of ‘in’ and ‘out’ connections was constrained to be 
the same (<k>=2). Inset: the out-degree distribution (kout) for each connection 
scheme: increasing preferential connection resulted in networks with a small number 
of highly out-connected nodes (cluster of low frequency green and blue points with 
high kout). The networks were run from random initial conditions and random 
intrinsic frequencies for each of the 100 nodes. An order parameter R was calculated 










1 ϕ  ( iϕ  is 
the phase of the ith oscillator; T=100, N=100; R=1 represents complete entrainments, 
see Materials and Methods). 1000 networks were sampled randomly for each coupling 
strength. Shaded areas: standard deviations. At all coupling strengths, increasing 
centralization of oscillator coupling enhanced entrainment (blue curve > green curve 












10. Mob1-GFP localizes to SPB in phase with Cdc14 release 
during Cdc14 endocycles. 
 
Mob1 is an essential component of the mitotic exit network (MEN) (Stegmeier 
and Amon, 2004).  Mob1-GFP localizes to both daughter- and mother-orientated 
SPB during ME, coinciding with Cdc14 release (Yoshida and Toh-e, 2001).  It has 
been suggested that Mob1’s SPB localization is important for its activation, although 
a direct causal relationship has not been shown (Stegmeier and Amon, 2004).   
 
Cdc14 can dephosphorylate Cdc15, another essential MEN component upstream 
of Mob1, probably leading to full activation of the MEN (Jaspersen and Morgan, 
2000; Stegmeier et al., 2002).  In order to study whether MEN activity also oscillates 
during the Cdc14 endocycles, I examined the localization of Mob1-GFP in the Clb2kd 
pulse experiment.  In 9/10 cells showing Cdc14 endocycles, Mob1-GFP localization 
also changed periodically, and its SPB localization coincided with Cdc14 release (Fig. 
4.22).  This observation suggests that the MEN activity may also oscillate during the 
Cdc14 endocycles, although I lack a technical means to directly measure Dbf2 kinase 





Figure 4.22.  Mob1-GFP localization during the Cdc14 endocycles.  
MET-CDC20 MOB1-GFP CDC14-YFP NET1-mCherry cells were pulsed with 
Clb2kd for 30 minutes as in Fig. 4.1D, and released into cell cycle.  The maximum 
GFP intensity was used a proxy for Mob1-GFP SPB localization (higher value 
indicates stronger SPB localization).  In 9/10 cell showing Cdc14 endocycles, 
Mcm2-GFP SPB localization appeared to oscillate in-phase with Cdc14 release.  
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11. Bypassing the lethality of cdc14Δ and the role of Cdc14 
phosphatase activity in its resequestration 
 
Cdc14 is normally essential for cell viability.  It has been shown that shortening 
the length of rDNA allows GAL1-SIC1 overexpression to rescue the cdc14-1 
temperature sensitive allele at restrictive temperatures (Machin et al., 2006).  I 
created a cdc14Δ strain with shortened rDNA and GAL1-SIC1 overexpression.  This 
strain was viable and slow-growing on galactose medium, but totally inviable on 
glucose medium (without Sic1 overexpression).   
 
The existence of this strain strongly suggests that the cyclin-Cdk cycle is 
intrinsically more important and primary in cell cycle regulation than the Cdc14 cycle; 
this idea is consistent with the universal conserved role of cyclin-Cdk in regulating 
the eukaryotic cell cycle, as compared to the more variable and less central role of 
Cdc14 in other eukaryotes (Morgan, 2007).  A similar strain construction 
demonstrated that the anaphase-promoting complex is dispensable provided that 
periodic cyclin-Cdk regulation is allowed (Thornton and Toczyski, 2003).  These 
results suggest that cyclin-Cdk is truly the ultimate driver of cell cycle regulation. 
In addition, the cdc14Δ strain can be employed to study an important question: 
whether Cdc14 resequestration into nucleolus requires Cdc14 phosphatase activity.  
Cdc14 has been proposed to promote its return to the nucleolus after release by 
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dephosphorylating several targets including Bub2, Lte1, Cdh1, and Net1 (Stegmeier 
and Amon, 2004).  However, inactivating Cdc14 phosphatase activity usually leads 
to mitotic cyclin stabilization and ME block.  Mitotic cyclin-Cdk activity also 
controls Cdc14 localization, which complicates the explanation of results as to 
whether the Cdc14 requirement for its nucleolar resequestration it is due to lack of 
Cdc14 phosphatase activity per se or due to high mitotic cyclin-Cdk activity.  (These 
activities are further intertwined by the likely direct dephosphorylation of multiple 
cyclin-Cdk targets by Cdc14).  
 
I employed the cdc14Δ strain to address this problem.  I introduced a 
phosphatase-inactive cdc14C283S/R289A-GFP construct into the cdc14Δ background 
(with shortened rDNA and GAL-SIC1 expression).  The catalytically inactive 
cdc14C283S/R289A-GFP had essentially no effect on the strain’s phenotype, which 
included massive cytokinetic defects and frequent cell cycle arrest.  I used time-lapse 
microscope to specifically examine cycling cells, to observe localization changes of 
catalytically inactive Cdc14.  Within this population, 17/21 cells under investigation 
demonstrated a clear release/resequestration pattern comparable to that of wild type 
cells (Fig. 4.23).  Occasionally, Cdc14 release lasted longer than the 20 minutes 
characteristic of wild-type.  The amplitude of Cdc14 release appeared to be smaller 
than wild type, but due to the elongated cell morphology in cdc14C283S/R289A-GFP 
GAL1-SIC1 cells, direct quantitative comparison with wild type cells is difficult.  
Therefore, I conclude that Cdc14 phosphatase activity may contribute to, but is not 
168
strongly required for Cdc14 resequestration.  In the absence of Cdc14 phosphatase 
activity, other phosphatases may also dephosphorylate relevant targets after mitotic 
cyclin inactivation to promote Cdc14 resequestration, especially with strong 











Figure 4.23.  The phosphatase activity of Cdc14 is not absolutely required for its 
nuclear sequestration.  cdc14::cdc14C283S/R289A-GFP NET1-mcherry 
GAL1-SIC1 short-rDNA was grown in galactose medium and analyzed using 
time-lapse microscopy.  Due to massive growth defects, only cycling cells were 
picked up.  3 cell lineages show that Cdc14 nucleolar localization is still cell cycle 
regulated in dividing cells (n=15). Traces are shifted along Y-axis for presentation. 






Here, I propose that an intrinsic oscillatory module controls Cdc14 release, and 
that cyclin-Cdk oscillation could order Cdc14 release, and likely other cell cycle 
events under independent oscillator control, by phase-locking these modules to the 
frequency of the cyclin-Cdk cycle.  
 
I describe the capacity of Cdc14 release and resequestration to oscillate 
spontaneously, independent of Clb-Cdk oscillations and thus independent of the main 
cell cycle driver.  This oscillatory module functioned at varying fixed Clb2-Cdk 
levels; importantly, though, Clb-Cdk levels nevertheless regulated the Cdc14 
oscillator, with higher Clb-Cdk increasing Cdc14 release frequency.   
 
The canonical model for once-per-cell-cycle regulation by cyclin-Cdk oscillations 
proposes that high and low cyclin-Cdk levels promote alternating steps of a process; I 
refer to this as a ‘ratchet’ model (see Introduction).  Such a model rather clearly 
predicts that any given fixed level of cyclin-Cdk should result in a terminal arrest with 
one or the other steps of each cell cycle process completed and the next never 
occurring.  Cdc14 endocycles at fixed Clb2 levels are hard to reconcile with this idea; 
further, there are at least three other once-per-cell-cycle events that are now known to 
have the potential to occur in a cyclical fashion independent of cyclin-Cdk oscillations: 
budding, cell-cycle-regulated transcription, and SPB duplication.  As an alternative 
to ratchet models, to account for existence and entrainment of these endocycles at a 
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common frequency, I propose here a phase-locking model by Cdk oscillation to order 
cell cycle events.   
 
It is important to note that such a phase-locking model is consistent with 
mechanistic regulatory details that are frequently interpreted as support for ratchet 
models; for example, the documented ability of high mitotic cyclin-Cdk activity to 
prevent SPB ‘licensing’ for duplication is not somehow ‘eliminated’ by a 
phase-locking model – it is considered as a mechanism of oscillator coupling.  The 
phase-locking model may provide deeper insight into cell cycle regulation since it 
incorporates the endocycle phenotypes, which despite the accumulation of an 
increasing number of examples, must be regarded as ‘outliers’ or artifacts in order to 
maintain the generality of ratchet-type models.  I generated and tested qualitative 
predictions of phase-locking models that clearly differ from the predictions of ratchet 
models, and the phase-locking model appeared to give a better fit.  
 
Further, I generated a simple but quantitative phase-locking model with 
parameters estimated solely from experiments on cells blocked in the cell cycle by 
undegradable mitotic cyclin.  This model then predicted Cdc14 release from the 
nucleolus late in the cell cycle, as the Clb-Cdk level is declining, as is observed 
experimentally.  This result is empirically meaningful since estimates from blocked 
cells, placed in the phase-locking model, yielded a correct answer for freely cycling 
cells, suggesting that the normal Cdc14 release cycles and endocycles are closely 
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related phenotypes, likely driven by the same oscillatory module.  
 
The predominant model for cell cycle control involves direct cyclin-Cdk control 
of cell cycle events, with surveillance checkpoints to ensure order.  An earlier model, 
derived from the study of cdc mutants (Morgan, 2007), considered cell cycle control 
to be due to parallel, interlocking but unidirectional morphogenetic pathways 
arranged in a functional sequence map.  My phase-locking model combines aspects 
of both models: a central cyclin-Cdk oscillator drives the cell cycle as in the first 
model; functional sequences emerge in the phase-locking model as independent 
oscillatory modules controlling specific cell cycle events.  Such independent cyclical 
processes are highly analogous to ‘independent functional sequences’ in the original 
cdc formulation – processes that can operate freely in parallel, such as DNA 
replication and spindle morphogenesis (Hartwell, 1974).  Such an arrangement gives 
great flexibility and resistance to deleterious effects of delays, once surveillance 
‘checkpoint’ mechanisms are in place.  Phase-locking of these autonomous 
oscillators by a central Cdk pacemaker could have been an important early event in 
cell cycle evolution, and this mechanism may control multiple autonomous cell cycle 




13. Unsolved issues 
 
1. What is the nature of the small amplitude oscillation of Cdc14 release in cdh1Δ 
cells with >2x peak Clb2kd?  I did not observe this small amplitude oscillation in 
the presence of CHX, indicating that transcriptional regulation may also drive this 
phenotype.  I have shown that Cdc14 release induced by Esp1 overexpression is 
more nuclear-concentrated in cdh1Δ cells than CDH1+ (Fig. 3.15).  Therefore, 
the reduced amplitude may reflect the fact that Cdc14 can still concentrates in the 
nucleus after nucleolar release; assuming microscopic colocalization of some of 
the nuclear-concentrated Cdc14 with nucleolar Net1 (a reasonable assumption 
given imperfect geometry and the close contact between nucleus and nucleolus), 
the quantitative measure of Cdc14 release would necessarily adopt a lower 
amplitude even if fully released from the nucleolus.  High levels of mitotic 
cyclin-Cdk may block Cdc14 nuclear export (Fig. 3.15), which is also consistent 
with this observation.   
 
2. Does oscillation of MEN activity drive the Cdc14 endocycle in cdh1 sic1 bub2 
cells? and what is role of MEN in promoting Cdc14 endocycles in Clb2kd cells, if 
any?  Using Mob1-GFP construct to observe its SPB localization may answer 
this question.  
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3. What is the threshold of Cdc5 for Cdc14 release?  I observed that Cdc14 release 
amplitude is not controlled by Clb2kd levels.  The digital behavior of Cdc14 
release can be explained by either positive feedbacks in Cdc14 control network or 
a sharp threshold for the Cdc5 level.  To determine the Cdc5 threshold, cells 
should be blocked in telophase by depleting Cdc5 using cdc5::MET3-CDC5.  
Then various concentrations of stable Cdc5-ΔNT-GFP could be expressed in the 
cell to correlate Cdc14 localization changes with Cdc5 level, as I did for 
Clb2kd-GFP. 
 
4.  If Cdc14 release controlled by Cdk oscillation through phase-locking, why is 
DNA replication much more likely controlled through a ratchet mechanism?  
Besides the possibility that those two events followed different evolutionary 
routes, it is possible that phase-locking and ratchet mechanisms may have 
specific advantages that make them suitable for different circumstances.  Cdc14 
endocycles may be utilized by the cells under certain physiological conditions.  
The likely ability of Cdc14 to inactivate the spindle checkpoint (see above) 
combined with potential Cdc14 oscillations under some conditions marginally 
activating the checkpoint, could periodically provide an escape ‘opportunity’ for 
checkpoint-arrested cells, i.e., a recovery mechanism.  In this context, it is 
interesting that adaptation to some forms of checkpoint arrest has been linked to 
Cdc5 (Toczyski et al., 1997), which is essential for Cdc14 release, including in 
endocycles (see above).  Periodic chromosome decondensation/recondensation 
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in animal cells blocked in mitosis with colcemid is a classical observation that 
comes to mind.  Formally similar proposals have been made to rationalize the 
physiological significance of the Mdm2-p53 oscillation in mammalian cells after 
DNA damage, where the oscillatory phenotype could be important for DNA 
damage repair.   
 
5.  Can the cell cycle be driven by oscillation of phosphates activity alone?  Free 
control of Cdc14 localization or activity may be important for answering this 
question.  Besides deleting NET1, constitutive Cdc14 release throughout the cell 
cycle has not been achieved (and net1 deletion in fact does not result in full 
release of Cdc14, as I showed in Chapter 3, since Cdc14 is largely 
nuclear-restricted in the absence of Net1).  Using GAL/MET-URL-CDC14-YFP 
construct, and periodically controlling promoter activities with a microfluidic 
system could be feasible, to see if normal cell cycle progression can be achieved 
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Theory and complexity 
 
 One familiar with images of fractals may be amazed by the great details of their 
fine structures.  However, a fractal image is usually generated by a rather short 
computer program, typically less than 100 letters.  Does the short program contain 
the same amount of information as the fractal images it generates?  What if the 
generation involves uncertainty or noise?  
 
 The organic world contains unlimited possibility and complexity, which 
traditional methodology, namely reductionism, appears rather inefficient in dealing 
with.  There must be at least two reasons: 1. Complexity is an inherent property of 
any biological system that emerges from myriads of ‘frozen incidences’ during billon 
years of evolution.   Meanwhile, its evolvability depends on the ability to generate 
enough phenotypic variations.  2. Partially due to the first reason, biologists are 
usually satisfied with qualitative results on their questions, which creates ambiguity 
and even leads to wrong conclusions.  Just like looking at ultra-low resolution 
images.  The same object could appear quite differently, and different objects could 
appear the same. 
 
 The contribution of theories to understanding biology is subtle, most successfully 
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in summarizing experimental results.  Better ones could reflect dynamic modes 
common in different systems.  To me, a good theory should provide a novel way of 
reasoning, even about old things.  Information theory and game theory, for example, 
do not solve previously forbidden questions, but provide a natural and concise way to 
re-analyze them, thus increase the efficiency of human brains at working on questions 
which they are not evolved to be good at.  Therefore, ‘concepts’ may be what we 
really need. 
 
 We can not consider that there is a simple common principle underlying each 
phenomenon within different systems, more than a wish.  Due to the complexity of 
its nature, it’s often necessary to neglect some facts when trying to summary a 
theoretical model.  The mind primed by any particular model or paradigm tends to 
discriminate among experimental approaches and results, intentionally or 
unintentionally, merely for the simplicity and beauty of its proof.  ‘It’s a tragedy 
when a beautiful theory in physics is disproved by ugly experiments.’  In biology, it 
only means the theory is not beautiful enough. 
 
 To understand or apply any theoretical model, it is very important to distinguish 
between what should happen and what actually happened.  Models of any kinds are 
merely ways to describe and justify observations, for our own convenience.  This 
straightforward notion tends to be ignored by many, mostly because, I think, blurring 
the distinction between theory and reality is important for cultivating intuitions, 
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although sometimes, quite misleading. 
 
Efficiency and curiosity 
  
 When you lose something, do you immediately search all possible places, or take 
some time first to think carefully where it could be?  Conducting biological research 
sometimes is like looking for lost things, except that what you find may not be what 
you expected. 
 
 Biologists are accumulating information at an amazing speed.  Eventually, any 
particular question will be answered, slowly but surely (physicists are less lucky in 
this aspect).  The real question is how to get there most efficiently.  After the goal is 
enlightened by curiosity, collecting all available information and analyzing it is the 
first step.  That allows distinguishing promising way(s) to go.  It is also important 
to wander around occasionally to avoid or escape traps on the path.  A similar idea is 
called ‘simulated annealing’, and has been quite useful to me. 
 
 The progression of science seldom follows people’s expectation.  Intellectual 
works of great brains shine only as time goes by.  Certain attempts that will almost 
for sure not fall into that category, such as conducting biological experiments catering 
a well-established model to establish faked satisfaction to the lay, in that neither new 
information nor fresh ways of analysis is provided, shall be avoided in any cases.   
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